{
  "resourceType": "ImplementationGuide",
  "id": "tewhatuora.nzhts",
  "url": "fhir-ig.digital.health.nz/nzhts/ImplementationGuide/tewhatuora.nzhts",
  "version": "0.1.0",
  "name": "nzhts",
  "title": "New Zealand Health Terminology Service (NZHTS) Implementation Guide",
  "status": "draft",
  "publisher": "Health New Zealand | Te Whatu Ora",
  "contact": [
    {
      "name": "Health New Zealand | Te Whatu Ora",
      "telecom": [
        {
          "system": "url",
          "value": "https://www.tewhatuora.govt.nz/"
        }
      ]
    }
  ],
  "description": "FHIR Iimplementation Guide for the NZHTS generated from the NZHTS API",
  "packageId": "tewhatuora.nzhts",
  "fhirVersion": [
    "4.0.1"
  ],
  "definition": {
    "resource": [
      {
        "reference": {
          "reference": "OperationOutcome/absent-or-unknown-devices-uv-ips"
        },
        "exampleBoolean": false,
        "name": "absent-or-unknown-devices-uv-ips"
      },
      {
        "reference": {
          "reference": "OperationOutcome/absent-or-unknown-problems-uv-ips"
        },
        "exampleBoolean": false,
        "name": "absent-or-unknown-problems-uv-ips"
      },
      {
        "reference": {
          "reference": "CodeSystem/practitioner-additional-authorisation"
        },
        "description": "Additional authorisations that a practitioner is authorised to practice or prescribe.",
        "exampleBoolean": false,
        "name": "Additional Authorisation"
      },
      {
        "reference": {
          "reference": "CodeSystem/administrative-gender"
        },
        "description": "The gender of a person used for administrative purposes.",
        "exampleBoolean": false,
        "name": "AdministrativeGender"
      },
      {
        "reference": {
          "reference": "CodeSystem/feb410e5-024e-4a8b-83c9-3b6a214b0d56"
        },
        "description": "Admission source code for use when reporting into National Collections",
        "exampleBoolean": false,
        "name": "Admission source code"
      },
      {
        "reference": {
          "reference": "CodeSystem/05d9a401-d679-413f-887f-4008a3977ffd"
        },
        "description": "Admission types to be used for reporting into National Collections",
        "exampleBoolean": false,
        "name": "Admission type code"
      },
      {
        "reference": {
          "reference": "ValueSet/admission-source-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/admission-source-code",
        "exampleBoolean": false,
        "name": "admission-source-code"
      },
      {
        "reference": {
          "reference": "ValueSet/adverse-event-severity"
        },
        "description": "All codes for http://terminology.hl7.org/CodeSystem/adverse-event-severity",
        "exampleBoolean": false,
        "name": "adverse-event-severity"
      },
      {
        "reference": {
          "reference": "CodeSystem/0b2c2a2a-0ea2-4a63-96f4-cc02c7c4ea23"
        },
        "description": "Agency type code to be used in reporting to National Collection",
        "exampleBoolean": false,
        "name": "Agency type code"
      },
      {
        "reference": {
          "reference": "ValueSet/ca2f975e-29e5-4d64-a14f-be0c815de94b"
        },
        "description": "List of diseases covered by the Aotearoa Immunisation Register",
        "exampleBoolean": false,
        "name": "AIR diseases covered code"
      },
      {
        "reference": {
          "reference": "CodeSystem/b4f184bd-bda7-43b2-899d-dca049b16286"
        },
        "exampleBoolean": false,
        "name": "AIR legacy codes"
      },
      {
        "reference": {
          "reference": "ValueSet/6a49d287-a077-454b-90cd-14d56e0ab089"
        },
        "exampleBoolean": false,
        "name": "AIR route of administration"
      },
      {
        "reference": {
          "reference": "ValueSet/4f1fd9c0-b6f7-46ba-acec-155be34d15fc"
        },
        "exampleBoolean": false,
        "name": "AIR status reason code"
      },
      {
        "reference": {
          "reference": "ValueSet/alias-type-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/alias-type-code",
        "exampleBoolean": false,
        "name": "alias-type-code"
      },
      {
        "reference": {
          "reference": "ValueSet/allergy-intolerance-category"
        },
        "description": "All codes for http://hl7.org/fhir/allergy-intolerance-category",
        "exampleBoolean": false,
        "name": "allergy-intolerance-category"
      },
      {
        "reference": {
          "reference": "ValueSet/allergy-intolerance-type"
        },
        "description": "All codes for http://hl7.org/fhir/allergy-intolerance-type",
        "exampleBoolean": false,
        "name": "allergy-intolerance-type"
      },
      {
        "reference": {
          "reference": "OperationOutcome/allergy-intolerance-uv-ips"
        },
        "exampleBoolean": false,
        "name": "allergy-intolerance-uv-ips"
      },
      {
        "reference": {
          "reference": "ValueSet/allergyintolerance-clinical"
        },
        "description": "All codes for http://terminology.hl7.org/CodeSystem/allergyintolerance-clinical",
        "exampleBoolean": false,
        "name": "allergyintolerance-clinical"
      },
      {
        "reference": {
          "reference": "CodeSystem/allergy-intolerance-criticality"
        },
        "description": "Estimate of the potential clinical harm, or seriousness, of a reaction to an identified substance.",
        "exampleBoolean": false,
        "name": "AllergyIntoleranceCriticality"
      },
      {
        "reference": {
          "reference": "CodeSystem/reaction-event-severity"
        },
        "description": "Clinical assessment of the severity of a reaction event as a whole, potentially considering multiple different manifestations.",
        "exampleBoolean": false,
        "name": "AllergyIntoleranceSeverity"
      },
      {
        "reference": {
          "reference": "CodeSystem/AntiviralEligibilityCriteriaCode"
        },
        "exampleBoolean": false,
        "name": "Antiviral eligibility - criteria codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/AntiviralEligibilityWhenSymptomsStartedCodes"
        },
        "description": "Terms for clinicians to identify when symptoms started to determine if a person is eligible for the COVID-19 antiviral",
        "exampleBoolean": false,
        "name": "Antiviral eligibility - when symptoms started codes"
      },
      {
        "reference": {
          "reference": "ValueSet/anzsco"
        },
        "description": "All codes for https://nzhts.digital.health.nz/fhir/CodeSystem/anzsco",
        "exampleBoolean": false,
        "name": "anzsco"
      },
      {
        "reference": {
          "reference": "CodeSystem/atc-classification-system"
        },
        "description": "Anatomical Therapeutic Chemical (ATC) classification system",
        "exampleBoolean": false,
        "name": "ATC classification system"
      },
      {
        "reference": {
          "reference": "CodeSystem/atc-classification"
        },
        "description": "Anatomical Therapeutic Chemical (ATC) classification system",
        "exampleBoolean": false,
        "name": "ATC classification system"
      },
      {
        "reference": {
          "reference": "ValueSet/de7a2ec8-8e19-4039-8962-e4f6b89160c7"
        },
        "exampleBoolean": false,
        "name": "ATC value set"
      },
      {
        "reference": {
          "reference": "CodeSystem/anzsic"
        },
        "description": "Australian and New Zealand Standard Industrial Classification",
        "exampleBoolean": false,
        "name": "Australian and New Zealand Standard Industrial Classification"
      },
      {
        "reference": {
          "reference": "ValueSet/building-type-code"
        },
        "exampleBoolean": false,
        "name": "Building type code"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-test-ns1"
        },
        "description": "Canshare testing non-snomed concepts",
        "exampleBoolean": false,
        "name": "Canshare testing non-snomed concepts"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-moh-refcrit-colonoscopy-2w"
        },
        "description": "All codes for http://canshare.co.nz/fhir/CodeSystem/canshare-moh-refcrit-colonoscopy-2w",
        "exampleBoolean": false,
        "name": "canshare-moh-refcrit-colonoscopy-2w"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-test-nonsnomed"
        },
        "description": "canshare-test-nonsnomed",
        "exampleBoolean": false,
        "name": "canshare-test-nonsnomed"
      },
      {
        "reference": {
          "reference": "CodeSystem/046609aa-c4d8-4dbd-add5-cd65164d4d45"
        },
        "description": "Clinical code type code for use when reporting into National Collections",
        "exampleBoolean": false,
        "name": "Clinical code type code"
      },
      {
        "reference": {
          "reference": "CodeSystem/2b7e5c24-4a1f-4271-9acf-9bc26338d576"
        },
        "description": "Clinical coding system code to be used for reporting to National Collections",
        "exampleBoolean": false,
        "name": "Clinical coding system code"
      },
      {
        "reference": {
          "reference": "ValueSet/clinical-code-type-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/clinical-code-type-code",
        "exampleBoolean": false,
        "name": "clinical-code-type-code"
      },
      {
        "reference": {
          "reference": "ValueSet/ucum-common"
        },
        "description": "Commonly encountered UCUM units (for purposes of helping populate look ups.",
        "exampleBoolean": false,
        "name": "Common UCUM units"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-unpublished-concepts"
        },
        "exampleBoolean": false,
        "name": "Concepts that are not yet formally published"
      },
      {
        "reference": {
          "reference": "CodeSystem/condition-clinical"
        },
        "description": "Preferred value set for Condition Clinical Status.",
        "exampleBoolean": false,
        "name": "Condition Clinical Status Codes"
      },
      {
        "reference": {
          "reference": "ValueSet/condition-ver-status"
        },
        "description": "All codes for http://terminology.hl7.org/CodeSystem/condition-ver-status",
        "exampleBoolean": false,
        "name": "condition-ver-status"
      },
      {
        "reference": {
          "reference": "ValueSet/condition-severity"
        },
        "description": "Preferred value set for Condition/Diagnosis severity grading.",
        "exampleBoolean": false,
        "name": "Condition/Diagnosis Severity"
      },
      {
        "reference": {
          "reference": "ValueSet/contact-point-purpose-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/contact-point-purpose-code",
        "exampleBoolean": false,
        "name": "contact-point-purpose-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/contact-point-purpose"
        },
        "description": "The purpose of a ContactPoint - what it is used for.",
        "exampleBoolean": false,
        "name": "ContactPoint purpose"
      },
      {
        "reference": {
          "reference": "CodeSystem/country-code-2-alpha"
        },
        "description": "Country - New Zealand Standard Classification 2 alpha",
        "exampleBoolean": false,
        "name": "Country code 2 Alpha"
      },
      {
        "reference": {
          "reference": "CodeSystem/country-code-4-numeric"
        },
        "description": "country code 4 numeric",
        "exampleBoolean": false,
        "name": "country code 4 numeric"
      },
      {
        "reference": {
          "reference": "CodeSystem/coverage-category"
        },
        "description": "New Zealand codes for Coverage category types",
        "exampleBoolean": false,
        "name": "Coverage category"
      },
      {
        "reference": {
          "reference": "CodeSystem/coverage-type"
        },
        "description": "New Zealand codes for Coverage Types",
        "exampleBoolean": false,
        "name": "Coverage type"
      },
      {
        "reference": {
          "reference": "ValueSet/currency"
        },
        "exampleBoolean": false,
        "name": "Currency"
      },
      {
        "reference": {
          "reference": "ValueSet/current-smoking-status-uv-ips"
        },
        "description": "HL7 LOINC value set for smoking status.  Based on the HL7 Vocab and Structured Doc WG (formerly TC) consensus - per US CDC submission 7/12/2012 for smoking status terms.",
        "exampleBoolean": false,
        "name": "Current Smoking Status - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/ff7f1c0d-f15e-4d2f-8ae5-272970d87b4f"
        },
        "exampleBoolean": false,
        "name": "CVDRA Angina"
      },
      {
        "reference": {
          "reference": "ValueSet/54b19e2e-2ea0-4fa2-82e7-29492ac59e3a"
        },
        "exampleBoolean": false,
        "name": "CVDRA Coronary Artery Bypass Grafting"
      },
      {
        "reference": {
          "reference": "ValueSet/05d47548-16b5-4e0b-b6eb-1a4d99e9ffbe"
        },
        "exampleBoolean": false,
        "name": "CVDRA Diabetes"
      },
      {
        "reference": {
          "reference": "ValueSet/5d98be20-7190-4b34-aa11-ddd2b5cae326"
        },
        "exampleBoolean": false,
        "name": "CVDRA Family History Of Premature Ischaemic CVD"
      },
      {
        "reference": {
          "reference": "ValueSet/969a9936-ab90-4b69-8ed2-fdf28aa43413"
        },
        "exampleBoolean": false,
        "name": "CVDRA Heart failure"
      },
      {
        "reference": {
          "reference": "ValueSet/d104a745-6c8b-4803-9156-b9928b9111ff"
        },
        "exampleBoolean": false,
        "name": "CVDRA Hypercholesterolaemia"
      },
      {
        "reference": {
          "reference": "ValueSet/a99220d8-0199-4b75-9fe5-5f5192e7c768"
        },
        "exampleBoolean": false,
        "name": "CVDRA Ischaemic Stroke"
      },
      {
        "reference": {
          "reference": "ValueSet/26a5f0bf-fb4b-4efe-aa9a-64b497933734"
        },
        "exampleBoolean": false,
        "name": "CVDRA Percutaneous Coronary Intervention"
      },
      {
        "reference": {
          "reference": "ValueSet/7a2a4238-ac5d-4b0e-9b24-d9232d365e32"
        },
        "exampleBoolean": false,
        "name": "CVDRA Peripheral Vascular Disease"
      },
      {
        "reference": {
          "reference": "ValueSet/7f02beae-b0a9-4713-beba-fd591c8261c6"
        },
        "exampleBoolean": false,
        "name": "CVDRA Renal Failure"
      },
      {
        "reference": {
          "reference": "ValueSet/80e0f962-9b93-42cc-8b7e-c5f33713e0ac"
        },
        "exampleBoolean": false,
        "name": "CVDRA Smoking Status"
      },
      {
        "reference": {
          "reference": "ValueSet/55fd31a6-56e1-4370-bd46-8f1e0be8750c"
        },
        "exampleBoolean": false,
        "name": "CVDRA Transient Ischaemic Attack (TIA)"
      },
      {
        "reference": {
          "reference": "CodeSystem/datum-code"
        },
        "description": "Possible datum codes",
        "exampleBoolean": false,
        "name": "Datum codes"
      },
      {
        "reference": {
          "reference": "ValueSet/dod-information-source"
        },
        "description": "The source from where the date of death was sourced",
        "exampleBoolean": false,
        "name": "Death date Information Source"
      },
      {
        "reference": {
          "reference": "ValueSet/dhb-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/dhb-code",
        "exampleBoolean": false,
        "name": "dhb-code"
      },
      {
        "reference": {
          "reference": "OperationOutcome/diagnostic-report-status"
        },
        "exampleBoolean": false,
        "name": "diagnostic-report-status"
      },
      {
        "reference": {
          "reference": "ValueSet/document-mode"
        },
        "description": "Whether the application produces or consumes documents.",
        "exampleBoolean": false,
        "name": "DocumentMode"
      },
      {
        "reference": {
          "reference": "CodeSystem/36d65fe3-ec80-48ad-af71-604abd675687"
        },
        "description": "Te Whatu Ora list of domicile codes",
        "exampleBoolean": false,
        "name": "Domicile Code"
      },
      {
        "reference": {
          "reference": "ValueSet/domicile-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/domicile-code",
        "exampleBoolean": false,
        "name": "domicile-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/87ef165b-b4fe-4944-bb0a-db6305063d3c"
        },
        "description": "DSM-IV",
        "exampleBoolean": false,
        "name": "DSM-IV"
      },
      {
        "reference": {
          "reference": "ValueSet/dwelling-type"
        },
        "exampleBoolean": false,
        "name": "Dwelling type"
      },
      {
        "reference": {
          "reference": "CodeSystem/edqm-standardterms"
        },
        "description": "EDQM - Standard Terms used in Switzerland (aggregations of codes of ValueSets RouteOfAdministration, Dose Form, see original codes system defined in https://standardterms.edqm.eu/#)",
        "exampleBoolean": false,
        "name": "EDQM - Standard Terms"
      },
      {
        "reference": {
          "reference": "ValueSet/ethnic-group-level-4-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/ethnic-group-level-4-code",
        "exampleBoolean": false,
        "name": "ethnic-group-level-4-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/funded-programme"
        },
        "description": "Some sort of funded programme",
        "exampleBoolean": false,
        "name": "Funded Programme"
      },
      {
        "reference": {
          "reference": "ValueSet/healthnz-language-value-set"
        },
        "description": "This valueset can be used for the collection of languages spoken by patients and providers. It contains the full set of ISO 639-2 language codes. It also contains ISO 639-3 codes for Cantonese(yue), Mandarin(cmn) and New Zealand Sign language (nzs) as these languages are commonly recorded by health providers in New Zealand. To request other ISO 639-3 codes to be added to the valueset contact stamdards@tewhatuora.govt.nz.",
        "exampleBoolean": false,
        "name": "Health NZ language Value Set"
      },
      {
        "reference": {
          "reference": "ValueSet/3520735b-dfc0-437d-81d1-4668ffdac620"
        },
        "exampleBoolean": false,
        "name": "Health service type refset vs"
      },
      {
        "reference": {
          "reference": "ValueSet/hpi-practitioner-role-status-reason-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/hpi-practitioner-role-status-reason-code",
        "exampleBoolean": false,
        "name": "hpi-practitioner-role-status-reason-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/2368312e-e623-465d-a599-76336f03d2cf"
        },
        "description": "The feeding method of an infant at various stages post delivery",
        "exampleBoolean": false,
        "name": "Infant feeding method code"
      },
      {
        "reference": {
          "reference": "CodeSystem/information-source"
        },
        "description": "All possible sources of information",
        "exampleBoolean": false,
        "name": "Information Source"
      },
      {
        "reference": {
          "reference": "CodeSystem/ISO3166Part1"
        },
        "description": "ISO 3166-1 establishes codes that represent the current names of countries, dependencies, and other areas of particular geopolitical interest, on the basis of country names obtained from the United Nations.",
        "exampleBoolean": false,
        "name": "ISO 3166-1 Codes for the representation of names of countries and their subdivisions — Part 1: Country code"
      },
      {
        "reference": {
          "reference": "ValueSet/iso-639-2-and-3"
        },
        "description": "iso 639-2 and 639-3 language codes",
        "exampleBoolean": false,
        "name": "ISO 639 2 and 3 language codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/iso639-2"
        },
        "description": "**Description:** Codes for the representation of names of languages — Part 2: Alpha-3 code, is the second part of the ISO 639 standard, which lists codes for the representation of the names of languages. The three-letter codes given for each language in this part of the standard are referred to as Alpha-3 codes. There are 487 entries in the list of ISO 639-2 codes. There are 21 languages that have alternative codes for bibliographic or terminology purposes, this code system only contains those with terminology purposes. Administered by SIL",
        "exampleBoolean": false,
        "name": "ISO 639-2 Language Codes Alpha 3"
      },
      {
        "reference": {
          "reference": "CodeSystem/iso639-3"
        },
        "description": "**Description:** ISO 639-3 is a code that aims to define three-letter identifiers for all known human languages. At the core of ISO 639-3 are the individual languages already accounted for in ISO 639-2. The large number of living languages in the initial inventory of ISO 639-3 beyond those already included in ISO 639-2 was derived primarily from Ethnologue (15th edition). Additional extinct, ancient, historic, and constructed languages have been obtained from Linguist List. Administered by SIL",
        "exampleBoolean": false,
        "name": "ISO 639-3 Language Codes Alpha 3"
      },
      {
        "reference": {
          "reference": "ValueSet/iso3166-1-2"
        },
        "description": "All codes for urn:iso:std:iso:3166",
        "exampleBoolean": false,
        "name": "iso3166-1-2"
      },
      {
        "reference": {
          "reference": "CodeSystem/iwi"
        },
        "description": "Iwi and iwi-releated groups",
        "exampleBoolean": false,
        "name": "Iwi and iwi-releated groups"
      },
      {
        "reference": {
          "reference": "ValueSet/iwi-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/iwi-code",
        "exampleBoolean": false,
        "name": "iwi-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/language-classification-code"
        },
        "description": "Language classification code",
        "exampleBoolean": false,
        "name": "Language classification code"
      },
      {
        "reference": {
          "reference": "CodeSystem/ethnicityL4"
        },
        "description": "Codes to record a person’s ethnicity, drawn from Level 4 of the Ethnicity code system \ndescribed [here](http://aria.stats.govt.nz/aria/#ClassificationView:uri=http://stats.govt.nz/cms/ClassificationVersion/YVqOcFHSlguKkT17)",
        "exampleBoolean": false,
        "name": "Level 4 ethnicity codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/LOINC-2.76"
        },
        "description": "LOINC is a common language (set of identifiers, names, and codes) for clinical and laboratory observations.",
        "exampleBoolean": false,
        "name": "LOINC 2.76"
      },
      {
        "reference": {
          "reference": "CodeSystem/LOINC-2.77"
        },
        "description": "LOINC is a common language (set of identifiers, names, and codes) for clinical and laboratory observations.",
        "exampleBoolean": false,
        "name": "LOINC 2.77"
      },
      {
        "reference": {
          "reference": "CodeSystem/LOINC-2.78"
        },
        "description": "LOINC is a common language (set of identifiers, names, and codes) for clinical and laboratory observations.",
        "exampleBoolean": false,
        "name": "LOINC 2.78"
      },
      {
        "reference": {
          "reference": "CodeSystem/loinc-nz-local-order-code"
        },
        "exampleBoolean": false,
        "name": "LOINC NZ local order code"
      },
      {
        "reference": {
          "reference": "CodeSystem/loinc-nz-local-code"
        },
        "description": "A FHIR CodeSystem of NZPOCS Observation Code Set - NZ Specific Code",
        "exampleBoolean": false,
        "name": "LOINC_NZ_local_code"
      },
      {
        "reference": {
          "reference": "CodeSystem/medication-statement-status"
        },
        "description": "Medication Status Codes",
        "exampleBoolean": false,
        "name": "Medication status codes"
      },
      {
        "reference": {
          "reference": "OperationOutcome/medication-snomed-absent-unknown-uv-ips"
        },
        "exampleBoolean": false,
        "name": "medication-snomed-absent-unknown-uv-ips"
      },
      {
        "reference": {
          "reference": "ValueSet/medication-snomed-uv-ips"
        },
        "description": "This value set includes codes from SNOMED Clinical Terms®: descendants of 373873005 \\|Pharmaceutical / biologic product (product)\\| excluding the descendants of 787859002 \\|Vaccine product (medicinal product)\\|.",
        "exampleBoolean": false,
        "name": "Medications - SNOMED CT (IPS)"
      },
      {
        "reference": {
          "reference": "ValueSet/medicine-active-substances-uv-ips"
        },
        "description": "This value set includes codes from SNOMED Clinical Terms®: all descendants of 410942007 | Drug or medicament (substance)|.  \nFuture implementations should consider ISO 11238 Health informatics -- Identification of medicinal products -- Data elements and structures for the unique identification and exchange of regulated information on substances.",
        "exampleBoolean": false,
        "name": "Medicine Active Substances - IPS"
      },
      {
        "reference": {
          "reference": "CodeSystem/my-document-mode"
        },
        "description": "Whether the application produces or consumes documents.",
        "exampleBoolean": false,
        "name": "MyDocumentMode"
      },
      {
        "reference": {
          "reference": "CodeSystem/my-new-cs"
        },
        "description": "My New CS",
        "exampleBoolean": false,
        "name": "MyNewCS"
      },
      {
        "reference": {
          "reference": "CodeSystem/maoridescentcode"
        },
        "description": "Stats NZ's Māori descent codes",
        "exampleBoolean": false,
        "name": "Māori descent codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/21000210109-20230401"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "New Zealand integrated care module"
      },
      {
        "reference": {
          "reference": "CodeSystem/21000210109-20231001"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "New Zealand integrated care module"
      },
      {
        "reference": {
          "reference": "CodeSystem/21000210109-20240401"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "New Zealand integrated care module"
      },
      {
        "reference": {
          "reference": "CodeSystem/21000210109-20241001"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "New Zealand integrated care module"
      },
      {
        "reference": {
          "reference": "OperationOutcome/nhi-use-code"
        },
        "exampleBoolean": false,
        "name": "nhi-use-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/7d2ebb5d-7957-4ee1-951b-6f5632b82e5e"
        },
        "description": "Number of vessels identified in the umbilical cord",
        "exampleBoolean": false,
        "name": "Number of cord vessels code"
      },
      {
        "reference": {
          "reference": "CodeSystem/1303956008-20240101"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "Nutrition Care Process Terminology module"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-breast-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) breast clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-breast-clinical-stage-group"
        },
        "description": "The clinical stage groups that describe how far a breast cancer has grown and spread before initiation of treatment, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) breast clinical stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-breast-ct"
        },
        "description": "A clinical tumour stage (cT) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) breast clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-breast-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a breast tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) breast pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-breast-pt"
        },
        "description": "A pathological tumour stage (pT) of a breast tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) breast pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-AJCC8-residual-tumour"
        },
        "description": "AJCC (8th edition) residual tumour (R) category.",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) edition residual tumour category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-cervix-uteri-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital cervix uteri clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-cervix-uteri-pt"
        },
        "description": "A pathological tumour stage (pT) of a cervix uteri tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital cervix uteri pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-cervix-uteri-stage-group"
        },
        "description": "The stage group that describe how far a cervix uteri cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital cervix uteri stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-ct"
        },
        "description": "A clinical tumour stage (cT) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-ct"
        },
        "description": "A clinical tumour stage (cT) of a corpus uteri adenosarcoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri adenosarcoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-adenosarcoma-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri adenosarcoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri adenosarcoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-ct"
        },
        "description": "A clinical tumour stage (cT) of a corpus uteri carcinoma and carcinosarcoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-carcinoma-stage-group"
        },
        "description": "The stage group that describe how far a corpus uteri carcinoma and carcinosarcoma has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri carcinoma and carcinosarcoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a corpus uteri before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a corpus uteri leiomyosarcoma and endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-ct"
        },
        "description": "A clinical tumour stage (cT) of a corpus uteri leiomyosarcoma and endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-leiomyosarcoma-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri leiomyosarcoma and endometrial stromal sarcoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a corpus uteri tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-corpus-uteri-stage-group"
        },
        "description": "The stage group that describe how far a corpus uteri cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital corpus uteri stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-gestational-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a gestational trophoblastic tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital gestational trophoblastic disease pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-gestational-stage-group"
        },
        "description": "The stage group that describe how far a gestational trophoblastic cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital gestational trophoblastic disease stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a ovary, fallopian tube and primary peritoneal carcinoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-ct"
        },
        "description": "A clinical tumour stage (cT) of a ovary, fallopian tube and primary peritoneal carcinoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a ovary, fallopian tube and primary peritoneal carcinoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-ovary-fallopian-peritoneal-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a ovary, falliopian and primary peritoneal carcinoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-gen-ovary-fallopian-peritoneal-stage-group"
        },
        "description": "The stage group that describe how far a ovary, fallopian tube and peritoneal carcinoma has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital ovary and fallopian tube and primary peritoneal carcinoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a female genital tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-pt"
        },
        "description": "A pathological tumour stage (pT) of a female genital tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-stage-group"
        },
        "description": "The stage groups that describe how far a female genital cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vagina-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a vagina tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vagina pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vagina-pt"
        },
        "description": "A pathological tumour stage (pT) of a vagina tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vagina pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vagina-stage-group"
        },
        "description": "The stage group that describe how far a vagina cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vagina stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a vulva tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a vulva tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-pt"
        },
        "description": "A pathological tumour stage (pT) of a vulva tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-female-genital-vulva-stage-group"
        },
        "description": "The stage group that describe how far a vulva cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) female genital vulva stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-clinical-stage-group"
        },
        "description": "The clinical stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal clinical stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-ct"
        },
        "description": "A clinical tumour stage (cT) of a gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-pt"
        },
        "description": "A pathological tumour stage (pT) of a gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-colorectal-stage-group"
        },
        "description": "The stage groups that describe how far a gastrointestinal colon and rectum cancer has grown and spread, using chapter 20 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal colon and rectum stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-yp-stage-group"
        },
        "description": "A post therapy or post neoadjuvant therapy pathological tumour stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal pathological post therapy (neoadjuvant) stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-pathological-stage-group"
        },
        "description": "The pathological stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal pathological stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gi-pt"
        },
        "description": "A pathological tumour stage (pT) of a gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gist-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal stromal tumour clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gist-ct"
        },
        "description": "A clinical tumour stage (cT) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal stromal tumour clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gist-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal stromal tumour pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gist-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal stromal tumour pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-gist-pt"
        },
        "description": "A pathological tumour stage (pT) of a gastrointestinal stromal tumour (GIST) before initiation of treatment, using chapter 43 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) gastrointestinal stromal tumour pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-ct"
        },
        "description": "A clinical tumour stage (cT) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome), using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology cutaneous B cell or T cell non mycosis fungoides and non sezary syndrome lymphoma pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-hl-or-nhl-stage-group"
        },
        "description": "The stage groups that describe how far a Hodgkin or non Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology Hodgkin or non Hodgkin lymphoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-ct"
        },
        "description": "A clinical tumour stage (cT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-mf-or-ss-pt"
        },
        "description": "A pathological tumour stage (pT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology mycosis fungoides or sezary syndrome pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a haematologic cancer, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-paed-hl-stage-group"
        },
        "description": "The stage groups that describe how far a paediatric Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology pediatric Hodgkin lymphoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-pcm-stage-group"
        },
        "description": "The stage groups that describe how far a plasma cell myeloma has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology plasma cell myeloma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-ct"
        },
        "description": "A clinical tumour stage (cT) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-non-mf-or-ss-pt"
        },
        "description": "A pathological tumour stage (pT) of a cutaneous B cell or T cell lymphoma (non mycosis fungoides and non sezary syndrome), using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-haematology-stage-group"
        },
        "description": "The stage groups that describe how far a haematologic cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) haematology stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a neuroendocrine gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a neuroendocrine gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a neuroendocrine gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-colorectal-pt"
        },
        "description": "A pathological tumour stage (pT) of a neuroendocrine gastrointestinal colon and rectum tumour before initiation of treatment, using chapter 33 of the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal colon and rectum pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-pt"
        },
        "description": "A pathological tumour stage (pT) of a neuroendocrine gastrointestinal tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-neuroendocrine-gi-stage-group"
        },
        "description": "The stage groups that describe how far a neuroendocrine gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) neuroendocrine gastrointestinal stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-lung-ct"
        },
        "description": "A clinical tumour stage (cT) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic lung clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-lung-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a lung tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic lung pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-lung-pt"
        },
        "description": "A pathological tumour stage (pT) of a lung tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic lung pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-lung-stage-group"
        },
        "description": "The stage groups that describe how far a lung cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic lung stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pleural-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a malignant pleural mesothelioma tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pleural-ct"
        },
        "description": "A clinical tumour stage (cT) of a malignant pleural mesothelioma tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pleural-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pleural-stage-group"
        },
        "description": "The stage groups that describe how far a malignant pleural mesothelioma cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic malignant pleural mesothelioma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a thoracic tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-pt"
        },
        "description": "A pathological tumour stage (pT) of a thoracic tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-thymus-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic thymus clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-thymus-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic thymus clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-thymus-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a thymus tumour, using the AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic thymus pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm8-thoracic-thymus-stage-group"
        },
        "description": "The stage group that describe how far a thymus cancer has grown and spread, using AJCC cancer staging manual (8th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (8th edition) thoracic thymus stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cervix-uteri-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital cervix uteri clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cervix-uteri-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital cervix uteri clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cervix-uteri-ct"
        },
        "description": "A clinical tumour stage (cT) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital cervix uteri clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cervix-uteri-pt"
        },
        "description": "A pathological tumour stage (pT) of a cervix uteri tumour, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital cervix uteri pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cervix-uteri-stage-group"
        },
        "description": "The stage group that describe how far a cervix uteri cancer has grown and spread, using AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital cervix uteri stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-ct"
        },
        "description": "A clinical tumour stage (cT) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a female genital tumour, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a female genital tumour, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-vulva-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital vulva clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-vulva-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a vulva tumour, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital vulva pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm9-female-genital-vulva-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a vulva tumour, using the AJCC cancer staging manual (9th edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC (9th edition) female genital vulva pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-AJCC8-residual-tumour-clincal"
        },
        "description": "Residual tumour values on structured pathology request form (surgeon) to remove R1 - Microscopic residual tumour based on AJCC 8th edition.",
        "exampleBoolean": false,
        "name": "NZ AJCC 8th edition residual tumour category clinical"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-clinical-stage-group"
        },
        "description": "The clinical stage groups that describe how far a breast cancer has grown and spread before initiation of treatment, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast clinical stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-ct"
        },
        "description": "A clinical tumour stage (cT) of a breast tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a breast tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-pathological-stage-group"
        },
        "description": "The pathological stage groups that describe how far a breast cancer has grown and spread using information obtained from pathological examination of tissue samples, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast pathological stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-pt"
        },
        "description": "A pathological tumour stage (pT) of a breast tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-breast-stage-group"
        },
        "description": "The anatomic and prognostic stage groups that describe how far a breast cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC breast stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ajcc-staging-manual-edition"
        },
        "description": "A numbered edition of the AJCC (AJCC)'s cancer staging system.",
        "exampleBoolean": false,
        "name": "NZ AJCC cancer staging manual edition"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-cm"
        },
        "description": "A clinical distant metastasis stage (cM) before initiation of treatment, using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-clinical-stage-group"
        },
        "description": "The clinical stage groups that describe how far a cancer has grown and spread before initiation of treatment, using AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC clinical stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-cervix-uteri-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital cervix uteri clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-cervix-uteri-ct"
        },
        "description": "A clinical tumour stage (cT) of a cervix uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital cervix uteri clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-cervix-uteri-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a cervix uteri tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital cervix uteri pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-cervix-uteri-pt"
        },
        "description": "A pathological tumour stage (pT) of a cervix uteri tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital cervix uteri pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-cervix-uteri-stage-group"
        },
        "description": "The stage group that describe how far a cervix uteri cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital cervix uteri stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-ct"
        },
        "description": "A clinical tumour stage (cT) of a female genital tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a corpus uteri adenosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri adenosarcoma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-adenosarcoma-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri adenosarcoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri adenosarcoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a corpus uteri carcinoma and carcinosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-ct"
        },
        "description": "A clinical tumour stage (cT) of a corpus uteri carcinoma and carcinosarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri carcinoma and carcinosarcoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-carcinoma-stage-group"
        },
        "description": "The stage group that describe how far a corpus uteri carcinoma and carcinosarcoma has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri carcinoma and carcinosarcoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a corpus uteri tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a corpus uteri leimyosarcoma and endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-ct"
        },
        "description": "A clinical tumour stage (cT) of a corpus uteri leiomyosarcoma and endometrial stromal sarcoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-leiomyosarcoma-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri leiomyosarcoma and endometrial stromal sarcoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-gen-corpus-uteri-leiomyosarcoma-stage-group"
        },
        "description": "The stage group that describe how far a corpus uteri leiomyosarcoma and endometrial stromal sarcoma has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri leiomyosarcoma and endometrial stromal sarcoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-pt"
        },
        "description": "A pathological tumour stage (pT) of a corpus uteri tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-corpus-uteri-stage-group"
        },
        "description": "The stage group that describe how far a corpus uteri cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital corpus uteri stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-gestational-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a gestational trophoblastic tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital gestational trophoblastic disease pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-gestational-stage-group"
        },
        "description": "The stage group that describe how far a gestational trophoblastic cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital gestational trophoblastic disease stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a ovary, fallopian tube and primary peritoneal carcinoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-ovary-fallopian-peritoneal-pt"
        },
        "description": "A pathological tumour stage (pT) of a ovary, fallopian tube and primary peritoneal carcinoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital ovary and fallopian tube and primary peritoneal carcinoma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a female genital tumour, using the AJCC cancer staging manual (latest edition)..",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vagina-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a vagina tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vagina clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vagina-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vagina pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vagina-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vagina pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vagina-pt"
        },
        "description": "A pathological tumour stage (pT) of a vagina tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vagina pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vagina-stage-group"
        },
        "description": "The stage group that describe how far a vagina cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vagina stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vulva-ct"
        },
        "description": "A clinical tumour stage (cT) of a vulva tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vulva clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vulva-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vulva pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vulva-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vulva pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-female-genital-vulva-pt"
        },
        "description": "A pathological tumour stage (pT) of a vulva tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC female genital vulva pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-clinical-stage-group"
        },
        "description": "The pathogical stage groups that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal clinical stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-colorectal-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a gastrointestional colon and rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal colon and rectum clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-colorectal-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a gastrointestional colon and rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal colon and rectum clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-colorectal-ct"
        },
        "description": "A clinical tumour stage (cT) of a gastrointestional colon and rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal colon and rectum clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-colorectal-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestional colon and rectum tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal colon and rectum pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-colorectal-stage-group"
        },
        "description": "The stage groups that describe how far a gastrointestinal colon and rectum cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal colon and rectum stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gi-yp-stage-group"
        },
        "description": "A post therapy or post neoadjuvant therapy pathological tumour stage group that describe how far a gastrointestinal cancer has grown and spread, using AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal pathological post therapy (neoadjuvant) stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-ct"
        },
        "description": "A clinical tumour stage (cT) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a gastrointestional stromal tumour (GIST) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-gist-other-stage-group"
        },
        "description": "The stage groups that describe how far a gastrointestinal stromal tumour (GIST) small intestine and oesophageal and colon and rectum and mesenteric and peritoneal has grown and spread, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC gastrointestinal stromal tumour small intestine and oesophageal and colon and rectum and mesenteric and peritoneal stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-cll-or-sll-stage-group"
        },
        "description": "The stage groups that describe how far a chronic lymphocytic lymphoma or a small lymphocytic lymphoma has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology chronic lymphocytic leukemia or small lymphocytic lymphoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a haematologic cancer before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-non-mf-or-ss-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a cutaneous B cell or T cell lymphoma (non Mycosis fungoides and non-sezary syndrome), using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology cutaneous B cell or T cell non Mycosis fungoides and non-sezary syndrome lymphoma pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-hl-or-nhl-stage-group"
        },
        "description": "The stage groups that describe how far a Hodgkin or non-Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology Hodgkin or non-Hodgkin lymphoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-ct"
        },
        "description": "A clinical tumour stage (cT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-mf-or-ss-pt"
        },
        "description": "A pathological tumour stage (pT) of a mycosis fungoides or sezary syndrome cutaneous lymphoma, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology mycosis fungoides or sezary syndrome pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a haematologic cancer, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-pt"
        },
        "description": "A pathological tumour stage (pT) of a haematologic cancer, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-paed-hl-stage-group"
        },
        "description": "The stage groups that describe how far a paediatric Hodgkin lymphoma has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology pediatric Hodgkin lymphoma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-non-mf-or-ss-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a cutaneous B cell or T cell lymphoma (non Mycosis fungoides and non-sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-haematology-non-mf-or-ss-ct"
        },
        "description": "A clinical tumour stage (cT) of a cutaneous B cell or T cell lymphoma (non Mycosis fungoides and non-sezary syndrome) before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC haematology primary cutaneous B cell or T cell (non MF/SS) lymphoma clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-AJCC-residual-tumour"
        },
        "description": "AJCC residual tumour (R) category.",
        "exampleBoolean": false,
        "name": "NZ AJCC latest edition residual tumour category clinical"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-ct"
        },
        "description": "A clinical tumour stage (cT) of a neuroendocrine gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a neuroendocrine gastrointestional colon and rectum tumour before initiation of treatment, the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal colon and rectum clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-pt"
        },
        "description": "A pathological tumour stage (pT) of a neuroendocrine gastrointestional colon and rectum tumour before initiation of treatment, the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal colon and rectum pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-colorectal-stage-group"
        },
        "description": "The stage groups that describe how far a neuroendocrine gastrointestinal colon and rectum cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal colon and rectum stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a neuroendocrine gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a neuroendocrine gastrointestional tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-neuroendocrine-gi-stage-group"
        },
        "description": "The stage groups that describe how far a neuroendocrine gastrointestinal cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC neuroendocrine gastrointestinal stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-pm"
        },
        "description": "A pathological distant metastasis stage (pM), using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-pathological-stage-group"
        },
        "description": "The pathological stage groups that describe how far a cancer has grown and spread using information obtained from pathological examination of tissue samples, using AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC pathological stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-pt"
        },
        "description": "A pathological tumour stage (pT) of a tumour, using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-ypn"
        },
        "description": "A post therapy or post neoadjuvant therapy pathological regional lymph node stage (ypN) using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC post therapy (neoadjuvant) pathological N category (ypN)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-rcn"
        },
        "description": "A recurrence or retreatment clinical regional lymph node stage (rcN) before initiation of treatment, using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC recurrence or retreatment clinical N category (rcN)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-rpn"
        },
        "description": "A recurrence or retreatment pathological regional lymph node stage (rpN), using the AJCC cancer staging manual.",
        "exampleBoolean": false,
        "name": "NZ AJCC recurrence or retreatment pathological N category (rpN)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ajcc-staging-chapter"
        },
        "description": "A chapter within the AJCC staging manual, used to populate TNM staging values.",
        "exampleBoolean": false,
        "name": "NZ AJCC staging chapter"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-ct"
        },
        "description": "A clinical tumour stage (cT) of a thoracic tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-lung-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic lung clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-lung-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a lung tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic lung clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-lung-stage-group"
        },
        "description": "The stage groups that describe how far a lung cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic lung stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pleural-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a malignant pleural mesothelioma tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic malignant pleural mesothelioma clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pleural-pm"
        },
        "description": "A pathological distant metastasis stage (pM) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic malignant pleural mesothelioma pathological M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pleural-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic malignant pleural mesothelioma pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pleural-pt"
        },
        "description": "A pathological tumour stage (pT) of a malignant pleural mesothelioma tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic malignant pleural mesothelioma pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pleural-stage-group"
        },
        "description": "The stage groups that describe how far a malignant pleural mesothelioma cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic malignant pleural mesothelioma stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-pn"
        },
        "description": "A pathological regional lymph node stage (pN) of a thoracic tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic pathological N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-stage-group"
        },
        "description": "The stage groups that describe how far a thoracic cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-thymus-cm"
        },
        "description": "A clinical distant metastasis stage (cM) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic thymus clinical M category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-thymus-cn"
        },
        "description": "A clinical regional lymph node stage (cN) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic thymus clinical N category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-thymus-ct"
        },
        "description": "A clinical tumour stage (cT) of a thymus tumour before initiation of treatment, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic thymus clinical T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-thymus-pt"
        },
        "description": "A pathological tumour stage (pT) of a thymus tumour, using the AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic thymus pathological T category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-thoracic-thymus-stage-group"
        },
        "description": "The stage groups that describe how far a thymus cancer has grown and spread, using AJCC cancer staging manual (latest edition).",
        "exampleBoolean": false,
        "name": "NZ AJCC thoracic thymus stage group"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-acute-leukaemia-cancer-type"
        },
        "description": "The type of acute leukaemia haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer acute leukaemia cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-adrenal-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the adrenal gland excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer adrenal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-agressive-cancer-type"
        },
        "description": "The type of aggressive B cell lymphoma haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer aggressive B cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-agressive-nhl-cancer-type"
        },
        "description": "The type of aggressive non-Hodgkin B cell lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer aggressive non-Hodgkin B cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ann-arbor-lymphoma-stage"
        },
        "description": "The stage groups for lymphoma, defined using Ann Arbor staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer Ann Arbor lymphoma stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-lymphoid-cancer-type"
        },
        "description": "The type of B cell lymphoid haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer B cell lymphoid cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-lymphoid-substream"
        },
        "description": "The subcategory of B cell lymphoid haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer B cell lymphoid substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-lymphoma-cancer-type"
        },
        "description": "The type of B cell lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer B cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-basis-of-cancer-diagnosis"
        },
        "description": "Types of evidence that may be used to reach a cancer diagnosis.",
        "exampleBoolean": false,
        "name": "NZ cancer basis of diagnosis"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bl-ipi-prognostic-score"
        },
        "description": "The prognostic score for Burkitt lymphoma, defined using the Burkitt Lymphoma International Prognostic Index (BL-IPI) scoring system..",
        "exampleBoolean": false,
        "name": "NZ cancer BL-IPI prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bone-cancer-type"
        },
        "description": "The type of the primary bone solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer bone cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bone-other-topography"
        },
        "description": "The body location used to describe the point of origin for other bone cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer bone other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bone-pelvis-topography"
        },
        "description": "The body location used to describe the point of origin for pelvic bone cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer bone pelvis topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bone-thoracic-topography"
        },
        "description": "The body location used to describe the point of origin for thoracic bone cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer bone thoracic topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-bone-vertebral-column-topography"
        },
        "description": "The body location used to describe the point of origin for vertebral column cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer bone vertebral column topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-ancillary-studies"
        },
        "description": "The ancillary studies relevant to breast tumours.",
        "exampleBoolean": false,
        "name": "NZ cancer breast ancillary studies"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-clinical-behaviour-category"
        },
        "description": "The behaviour categories relevant to breast tumours by clincal examination.",
        "exampleBoolean": false,
        "name": "NZ cancer breast clinical behaviour category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-clinical-presentation"
        },
        "description": "The relevant clinical symptoms or findings for a breast cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast clinical presentation"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-breast"
        },
        "description": "Lymph nodes used for diagnosis of breast cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-mammogram-finding"
        },
        "description": "The radiologic findings relevant to breast tumours by mammographic imaging, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast mammogram finding"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-non-nac-topography"
        },
        "description": "The body location used to describe the point of origin for non nipple-areolar complex breast cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast non-nipple-areola complex topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-procedure-image-guided-method"
        },
        "description": "Procedure image guided methods relevant to breast, or an 'Other' or 'Not applicable' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast procedure image guided method"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-radiology-type"
        },
        "description": "Types of radiology imaging relevant to breast, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast radiology type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-related-topography"
        },
        "description": "A body location used to describe a body site in the breast or related to the breast (e.g. a lymph node) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast related topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-specimen-resection-procedure-type"
        },
        "description": "The resection procedure types relevant to breast specimens, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast resection procedure type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-breast-ultrasound-finding"
        },
        "description": "The radiologic findings relevant to breast tumours by ultrasound imaging, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer breast ultrasound finding"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-brain-topography"
        },
        "description": "The body location used to describe the point of origin for brain cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer central nervous system brain topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-meninges-topography"
        },
        "description": "The body location used to describe the point of origin for meninges cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer central nervous system meninges topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-nerve-topography"
        },
        "description": "The body location used to describe the point of origin for nerve cancer of the central nervous system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer central nervous system nerve topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-other-topography"
        },
        "description": "The body location used to describe the point of origin for other central nervous system cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer central nervous system other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-topography"
        },
        "description": "The body location used to describe the point of origin for central nervous system cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer central nervous system topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-clinical-scale"
        },
        "description": "A clinical assessment scale.",
        "exampleBoolean": false,
        "name": "NZ cancer clinical assessment scale"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-clinical-impression-behaviour"
        },
        "description": "The behaviour categories relevant to clinical impression of tumour behaviour.",
        "exampleBoolean": false,
        "name": "NZ cancer clinical impression of behaviour"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-clockface-position"
        },
        "description": "The clockface position values relevant when describing a tumour site.",
        "exampleBoolean": false,
        "name": "NZ cancer clockface position"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-cancer-type"
        },
        "description": "The type of the primary central nervous system (CNS) solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer CNS cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-melanoma-cns-topography"
        },
        "description": "The body location used to describe the point of origin for a CNS (central nervous system) melanoma or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer CNS melanoma topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-status-prognostic-score"
        },
        "description": "The prognostic score for reporting status in acute lymphoblastic lymphoma, defined using the central nervous system (CNS) prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer CNS status in acute lymphoblastic leukaemia lymphoma prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cns-ipi-prognostic-score"
        },
        "description": "The prognostic score for large B-cell lymphoma, defined using the Central Nervous System International Prognostic Index (CSN-IPI) scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer CNS-IPI for large B cell lymphoma prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-topography-colonoscopy"
        },
        "description": "Body sites that are accessed by a surgeon during a colonoscopy procedure or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer colonoscopy topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-cancer-type"
        },
        "description": "The type of the primary colorectal solid cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer colorectal cancer type"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-moh-refcrit-colonoscopy-6w"
        },
        "description": "The 6 week referral criteria published by the Ministry of Health for outpatient colonoscopies.",
        "exampleBoolean": false,
        "name": "NZ cancer colorectal colonoscopy 6 week referral criteria"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-colorectal-topography-subtype-metastectomy"
        },
        "description": "Body site subtypes that are accessed by a surgeon during a colorectal metastectomy procedure or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer colorectal metastectomy topography subtype"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-specimen-colorectal-screening-colonoscopy-type"
        },
        "description": "The type of colonoscopy specimen collected for a colorectal screening pathology request.",
        "exampleBoolean": false,
        "name": "NZ cancer colorectal screening colonoscopy specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-referral-criteria-surveillance"
        },
        "description": "The clinical indication(s) required for a referral into the colorectal surveillance colonoscopy pathway with the addition of other value.",
        "exampleBoolean": false,
        "name": "NZ cancer colorectal surveillance colonoscopy referral criteria"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-data-absent-reason"
        },
        "description": "A reason that no specific value is available.",
        "exampleBoolean": false,
        "name": "NZ cancer data absent reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-diagnosis-clinical-status"
        },
        "description": "The status of the primary diagnosis in terms of its clinical progression.",
        "exampleBoolean": false,
        "name": "NZ cancer diagnosis clinical status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-document-type"
        },
        "description": "The specific type of document, e.g. radiotherapy care plan.",
        "exampleBoolean": false,
        "name": "NZ cancer document type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eln-prognostic-score"
        },
        "description": "The prognostic score for reporting genetic alteration in acute myeloid leukaemia, defined using the European LeukemiaNet (ELN) prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer ELN standardised reporting for genetic alteration in AML prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-endocrine-neuroendocrine-cancer-type"
        },
        "description": "The type of the primary endocrine and neuroendocrine tumour solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer endocrine and neuroendocrine cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-endocrine-neuroendocrine-substream"
        },
        "description": "The subcategory of the primary endocrine and neuroendocrine tumour solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer endocrine and neuroendocrine substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-endocrine-neuroendocrine-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of an endocrine organ or a cancer with a neuroendocrine histology or 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer endocrine and/or neuroendocrine topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-endocrine-other-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of an endocrine organ (excluding pancreas and lymph nodes) and which is not a thyroid, parathyroid, adrenal or pituitary primary or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer endocrine other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-endocrine-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of an endocrine organ, excluding pancreas and lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer endocrine topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-er-expression"
        },
        "description": "An assessment of whether or not a tumour is estrogen receptive (ER).",
        "exampleBoolean": false,
        "name": "NZ cancer ER expression"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eutos-prognostic-score"
        },
        "description": "The prognostic score for chronic myeloid leukaemia, defined using the European Treatment and Outcome Study (EUTOS) prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer EUTOS for CML prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-excision-specimen-type"
        },
        "description": "The type of excision specimen collected for a pathology request or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer excision specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-cancer-type"
        },
        "description": "The type of primary eye and/or orbit solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-lacrimal-drainage-system-topography"
        },
        "description": "The body location used to describe the point of origin for lacrimal drainage system cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit lacrimal drainage system topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-lacrimal-gland-topography"
        },
        "description": "The body location used to describe the point of origin for lacrimal gland cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit lacrimal gland topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-eye-orbit"
        },
        "description": "Lymph nodes used for diagnosis of eye and orbit cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-optic-nerve-topography"
        },
        "description": "The body location used to describe the point of origin for optic nerve cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit optic nerve topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-other-topography"
        },
        "description": "The body location used to describe the point of origin for other eye and orbit cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-eye-orbit-uveal-tract-topography"
        },
        "description": "The body location used to describe the point of origin for uveal tract cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer eye and orbit uveal tract topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-female-genital-cervix-uteri"
        },
        "description": "Lymph nodes used for diagnosis of cervix uteri cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital cervix uteri lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-cervix-uteri-topography"
        },
        "description": "The body location used to describe the point of origin for cervix uteri cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital cervix uteri topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-female-genital-corpus-uteri"
        },
        "description": "Lymph nodes used for diagnosis of corpus uteri cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital corpus uteri lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-corpus-uteri-topography"
        },
        "description": "The body location used to describe the point of origin for corpus uteri cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital corpus uteri topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-fallopian-tube-topography"
        },
        "description": "The body location used to describe the point of origin for fallopian tube cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital fallopian tube topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-gestational-trophoblastic-topography"
        },
        "description": "The body location used to describe the point of origin for gestational trophoblastic disease cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital gestational trophoblastic disease topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-peritoneum-topography"
        },
        "description": "The body location used to describe the point of origin for peritoneum cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital peritoneum topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-uterine-ligament-topography"
        },
        "description": "The body location used to describe the point of origin for uterine ligament cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital uterine ligament topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-female-genital-vulva"
        },
        "description": "Lymph nodes used for diagnosis of vulva cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital vulva lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-female-genital-vulva-topography"
        },
        "description": "The body location used to describe the point of origin for vulva cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer female genital vulva topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-figo-2001-gestational-stage"
        },
        "description": "The stage groups for a gestational trophoblastic tumour, defined by International Federation of Gynecology and Obstetrics 2001 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer FIGO 2001 gestational trophoblastic disease stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-figo-2009-endometrial-carcinoma-stage"
        },
        "description": "The stage groups for an endometrial carcinoma, defined by International Federation of Gynecology and Obstetrics 2009 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer FIGO 2009 endometrial carcinoma stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-figo-2015-corpus-uteri-adenosarcoma-stage"
        },
        "description": "The stage groups for a corpus uteri adenosarcoma, defined by International Federation of Gynecology and Obstetrics 2015 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer FIGO 2015 corpus uteri adenosarcoma stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-figo-2018-cervix-uteri-stage"
        },
        "description": "The stage groups for a cervix uteri tumour, defined by International Federation of Gynecology and Obstetrics 2018 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer FIGO 2018 cervix uteri stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-figo-2021-vulva-stage"
        },
        "description": "The stage groups for a vulva tumour, defined by International Federation of Gynecology and Obstetrics 2021 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer FIGO 2021 vulva stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-flipi-prognostic-score"
        },
        "description": "The prognostic score for follicular lymphoma, defined using the Follicular Lymphoma International Prognostic Scoring (FLIPI) system.",
        "exampleBoolean": false,
        "name": "NZ cancer FLIPI prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-follicular-lymphoma-grade"
        },
        "description": "The grade of a follicular lymphoma, assessed using the follicular lymphoma grading system.",
        "exampleBoolean": false,
        "name": "NZ cancer follicular lymphoma grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-frozen-section-specimen-type"
        },
        "description": "The type of frozen section specimen collected for a pathology request an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer frozen section specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-anus-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) of the anus excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour anal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-appendix-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) of the appendix excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour appendix topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-colorectal-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) of the colorectum excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour colorectal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-other-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) which is not a hepatic NET, pancreas NET, anus NET, colorectal NET, appendix NET, small intestine NET or stomach NET, excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-pancreas-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) of the pancreas excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour pancreas topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-stomach-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) of the stomach excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour stomach topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gep-net-topography"
        },
        "description": "The body location used to describe the point of origin for a gastroenteropancreatic neuroendocrine tumour (GEP-NET) excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastroenteropancreatic neuroendocrine tumour topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-gastrointestinal-anus"
        },
        "description": "Lymph nodes used for diagnosis of gastrointestinal anal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal anus lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gastro-cancer-type"
        },
        "description": "The type of the primary gastrointestinal solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-colon-topography"
        },
        "description": "The body location used to describe the point of origin for colon cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal colon topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-gastrointestinal-colorectal"
        },
        "description": "Lymph nodes used for diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal colorectal lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-procedure-specimen-gi-cr-resection-met"
        },
        "description": "Specimen collection metastecomy resection procedures used in the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal colorectal metastecomy resection specimen collection procedure"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-colorectal-topography-resection"
        },
        "description": "Body sites that are accessed by a surgeon during a operative or endoscopic resection procedure or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal colorectal resection topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-colorectal-topography"
        },
        "description": "The body location used to describe the point of origin for colorectal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal colorectal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-procedure-specimen-gi-cr-diagnostic"
        },
        "description": "Specimen collection procedures used in small diagnostic procedures for the diagnosis of gastrointestinal colorectal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal diagnostic specimen collection procedure"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-duodenum-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the duodenum including ampulla of vater or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal duodenum topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-exocrine-pancreas-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the exocrine pancreas or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal exocrine pancreas topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-hep-pan-bil-topography"
        },
        "description": "The body location used to describe the point of origin for hepatopancreaticobiliary cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal hepatopancreaticobiliary topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-jejunum-ileum-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the ileum and jejunum or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal ileum and jejunum topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-liver-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the liver or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal liver topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-gastrointestinal"
        },
        "description": "Lymph nodes used for diagnosis of gastrointestinal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-oesophagus-topography"
        },
        "description": "The body location used to describe the point of origin for oesophageal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal oesophagus topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-pancreas-topography"
        },
        "description": "The body location used to describe the point of origin for pancreatic cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal pancreas topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-rectum-topography"
        },
        "description": "The body location used to describe the point of origin for rectal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal rectum topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-procedure-specimen-gi"
        },
        "description": "Specimen collection procedures used in the diagnosis of gastrointestinal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal specimen collection procedure"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-gastrointestinal-stomach"
        },
        "description": "Lymph nodes used for diagnosis of gastrointestinal stomach cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal stomach lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-stomach-topography"
        },
        "description": "The body location used to describe the point of origin for stomach cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal stomach topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gastro-substream"
        },
        "description": "The subcategory of the primary gastrointestinal solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer gastrointestinal substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-non-prostate-genitourinary-cancer-type"
        },
        "description": "The type of primary non prostate genitourinary solid cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer genitourinary (non prostate) cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-genitourinary-substream"
        },
        "description": "The subcategory of the primary genitourinary solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer genitourinary substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-german-hodgkin-stage"
        },
        "description": "The stage groups for Hodgkin lymphoma, defined using German Hodgkin Study Group (GHSG) staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer GHSG Hodgkin treatment stratification stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-grade"
        },
        "description": "The grade of a cancer",
        "exampleBoolean": false,
        "name": "NZ cancer grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-grading-system"
        },
        "description": "Grading systems used to assess the grade of one or more cancer types, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer grading system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-haematology-stream"
        },
        "description": "The category of haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer haematology stream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-haematology-substream"
        },
        "description": "The subcategory of haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer haematology substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-haematology-treatment-intent"
        },
        "description": "Intents or reasons for using a therapeutic procedure to treat haematological cancers.",
        "exampleBoolean": false,
        "name": "NZ cancer haematology treatment intent"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-cancer-type"
        },
        "description": "The type of the primary head and neck solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-hypopharynx-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the hypopharynx or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck hypopharynx topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-larynx-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the larynx or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck larynx topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-head-neck"
        },
        "description": "Lymph nodes used for diagnosis of head and neck cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-salivary-gland-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the major salivary gland or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck major salivary gland topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-nasal-paranasal-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the nasal cavity and/or paranasal sinus' or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck nasal cavity and paranasal sinus topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-nasal-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the nasal region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck nasal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-nasopharynx-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the nasopharynx or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck nasopharynx topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-odontogenic-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the jaw region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck odontogenic topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-other-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the head and neck which is not an ear, trachea, larynx, parapharyngeal, hypopharynx, oropharynx, nasopharynx, nasal, salivary gland, oral cavity or mobile tongue, thyroid or odontogenic primary, excluding skin topography and lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-substream"
        },
        "description": "The subcategory of the primary head and neck solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-head-neck-with-thyroid-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the head and neck and thyroid excluding skin topography and lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer head and neck with thyroid topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-health-worker-role-path-radio-surg"
        },
        "description": "The type of health worker role - including pathologist, radiologist and surgeon.",
        "exampleBoolean": false,
        "name": "NZ cancer health worker role pathologist radiologist surgeon"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-haem-recurrence-type"
        },
        "description": "The type of cancer recurrence used in a heamatology setting plus unknown and not applicable values.",
        "exampleBoolean": false,
        "name": "NZ cancer heamatology recurrence type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-high-level-topography"
        },
        "description": "The high-level body location used to describe the point of origin for all cancer types or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer high level topography"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-hl7-fhir-diagnostic-report-status"
        },
        "description": "The status of the diagnostic report.",
        "exampleBoolean": false,
        "name": "NZ cancer HL7 diagnostic report status"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-hl7-fhir-care-plan-status"
        },
        "description": "Codes identifying the lifecycle stage of a care plan request.",
        "exampleBoolean": false,
        "name": "NZ cancer HL7 FHIR care plan status"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-hl7-fhir-condition-verification-status"
        },
        "description": "The verification status to support or decline the clinical status of the condition or diagnosis.",
        "exampleBoolean": false,
        "name": "NZ cancer HL7 FHIR condition verification status"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-hl7-fhir-request-status"
        },
        "description": "Codes identifying the lifecycle stage of a request.",
        "exampleBoolean": false,
        "name": "NZ cancer HL7 FHIR request status"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-hl7-fhir-service-request-status"
        },
        "description": "Codes identifying the lifecycle stage of a service request (e.g. diagnostic tests, therapies, pharmacist medication review).",
        "exampleBoolean": false,
        "name": "NZ cancer HL7 FHIR service request status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-hl-ips-prognostic-score"
        },
        "description": "The prognostic score for Hodgkin lymphoma, defined using the Hodgkin lymphoma International Prognostic Score (IPS) system.",
        "exampleBoolean": false,
        "name": "NZ cancer Hodgkin lymphoma International Prognostic Score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-indolent-cancer-type"
        },
        "description": "The type of indolent B cell lymphoma haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer indolent B cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-b-cell-indolent-nhl-cancer-type"
        },
        "description": "The type of indolent non-Hodgkin B cell lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer indolent non-Hodgkin B cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ipss-r-prognostic-score"
        },
        "description": "The prognostic score for myelodysplastic syndrome, defined using the Revised International Prognostic Scoring System (IPSS-R).",
        "exampleBoolean": false,
        "name": "NZ cancer IPSS-R for MDS prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-laboratory-test-method"
        },
        "description": "Test method procedures used in laboratory studies or an \"other\" value.",
        "exampleBoolean": false,
        "name": "NZ cancer laboratory test method"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality"
        },
        "description": "The side of a paired organ (e.g. left or right).",
        "exampleBoolean": false,
        "name": "NZ cancer laterality"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality-mandatory"
        },
        "description": "The side of a paired organ (e.g. left or right) or a 'Not applicable' value.",
        "exampleBoolean": false,
        "name": "NZ cancer laterality mandatory"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality-optional"
        },
        "description": "The side of a paired organ (e.g. left or right) or an 'Unknown' or 'Not applicable' value.",
        "exampleBoolean": false,
        "name": "NZ cancer laterality optional"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality-or-side"
        },
        "description": "The side of a paired organ or midline structure, e.g. left, right, central.",
        "exampleBoolean": false,
        "name": "NZ cancer laterality or side "
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality-side-mandatory"
        },
        "description": "The laterality of a paired organ (e.g. left, right, bilateral) or the side of the body relative to the midline (e.g. left side, right side, central or both sides) or 'Not applicable'.",
        "exampleBoolean": false,
        "name": "NZ cancer laterality or side mandatory"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-laterality-with-unknown"
        },
        "description": "The side of a paired organ (e.g. left or right) or an 'Unknown' value.",
        "exampleBoolean": false,
        "name": "NZ cancer laterality with unknown value"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lower-gastro-cancer-type"
        },
        "description": "The type of the primary lower gastrointestinal solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer lower gastrointestinal cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lugano-lymphoma-stage"
        },
        "description": "The stage groups for lymphoma defined using the Lugano staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer Lugano staging classification for lymphoma"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymph-node-specimen-type"
        },
        "description": "The type of lymph node specimen collected for a pathology request or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer lymph node specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphoma-substream"
        },
        "description": "The subcategory of lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer lymphoma substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-male-genital"
        },
        "description": "Lymph nodes used for diagnosis of male genital cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer male genital lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-male-genital-sact-cancer-type"
        },
        "description": "The type of the primary male genital solid cancer being assessed and treated, by systemic anti-cancer therapy (SACT).",
        "exampleBoolean": false,
        "name": "NZ cancer male genital SACT cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-male-genital-topography"
        },
        "description": "The body location used to describe the point of original for male genital cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer male genital topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-malt-ipi-prognostic-score"
        },
        "description": "The prognostic score for marginal zone lymphoma of mucosa associated lymphoid tissue international prognostic index (MALT-IPI) prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer MALT-IPI prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mastocytosis-cancer-type"
        },
        "description": "The type of mastocytosis haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer mastocytosis cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-md-anderson-residual-cancer-burden"
        },
        "description": "The neoadjuvant therapy response score for breast, defined using the MD Anderson residual cancer burden system.",
        "exampleBoolean": false,
        "name": "NZ cancer MD Anderson residual cancer burden"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-cns-cancer-type"
        },
        "description": "The type of the primary central nervous system (CNS) solid cancer being assessed and treated, by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology cns cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-endocrine-cancer-type"
        },
        "description": "The type of the primary endocrine solid cancer being assessed and treated my medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology endocrine cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-genitourinary-cancer-type"
        },
        "description": "The type of the primary genitourinary solid cancer being assessed and treated, by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology genitourinary cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-gynaecological-cancer-type"
        },
        "description": "The type of the primary gynaecological solid cancer being assessed and treated, by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology gynaecological cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-head-neck-cancer-type"
        },
        "description": "The type of the primary head and neck solid cancer being assessed and treated, by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology head and neck cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-head-neck-other-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the head and neck which is not an ear, trachea, larynx, parapharyngeal, hypopharynx, oropharynx, nasopharynx, nasal, salivary gland, oral cavity or mobile tongue, thyroid or odontogenic primary, including skin topography and lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology head and neck other topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-male-genital-topography"
        },
        "description": "The body location used to describe the point of origin for male genital cancer or an 'Other' value, used for medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology male genital topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-head-neck-other-cancer-type"
        },
        "description": "The type of the primary head and neck other than oral cavity or mobile tongue primary, major salivary gland primary, odontogenic primary, nasal cavity and paranasal sinus primary, ear primary, pharynx, larynx and trachea primary solid cancer being assessed and treated by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology other head and neck cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-skin-melanoma-topography"
        },
        "description": "The body location used to describe the point of origin for skin cancer and/or melanoma or an 'Other' value for medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology skin and/or melanoma topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-skin-topography"
        },
        "description": "The body location used to describe the point of origin for a skin cancer or an 'Other' value for medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology skin topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-solid-tumour-cancer-type"
        },
        "description": "The type of the primary solid cancer being assessed and treated, by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology solid tumour cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-solid-tumour-substream"
        },
        "description": "The subcategory of the primary solid cancer being assessed and treated by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology solid tumour substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-thoracic-cancer-type"
        },
        "description": "The type of the primary thoracic solid cancer being assessed and treated by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology thoracic cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-treatment-intent"
        },
        "description": "Intents or reasons for using a therapeutic procedure to treat solid tumors under the supervision of a medical oncologist.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology treatment intent"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-urinary-male-genital-testicular-topography"
        },
        "description": "The body location used to describe the point of origin for testicular cancer or an 'Other' value, used for medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology urinary and male genital testicular topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-urinary-male-genital-topography"
        },
        "description": "The body location used to describe the point of origin for urinary and male genital cancer or an 'Other' value, used for medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medical oncology urinary and male genital topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-thoracic-substream"
        },
        "description": "The subcategory of the primary thoracic cancer being assessed and treated by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer medicial oncology thoracic substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-melanoma-cancer-type"
        },
        "description": "The type of the primary melanoma solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer melanoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-menopause-status"
        },
        "description": "The relevant values to classify the onset of menopause for a patient e.g. premenopausal, perimenopausal or postmenopausal.",
        "exampleBoolean": false,
        "name": "NZ cancer menopause status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-midline-non-symmetrical-topography"
        },
        "description": "A body structure where cancer may be present, which crosses midline but should not be referred to in sides (e.g. non-symmetrical, non-specific and lateralisable structures).",
        "exampleBoolean": false,
        "name": "NZ cancer midline non-symmetrical topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-midline-topography"
        },
        "description": "A body structure where cancer may be present, which is symmetrical on the body's midline or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer midline topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mipi-prognostic-score"
        },
        "description": "The prognostic score for mantle cell lymphoma, defined using the Mantle Cell Lymphoma International Prognostic Scoring (MIPI) system.",
        "exampleBoolean": false,
        "name": "NZ cancer MIPI prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mipss-70-v2-prognostic-score"
        },
        "description": "The prognostic score for myelofibrosis, defined using the Mutation-Enhanced International Prognostic Score System (MIPSS) age seventy-plus version two prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer MIPSS 70+ v2.0 myelofibrosis prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mds-myeloproliferative-cancer-type"
        },
        "description": "The type of myelodysplastic-myeloproliferative haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer myelodysplastic-myeloproliferative cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-myeloid-cancer-type"
        },
        "description": "The type of myeloid proliferation and myeloid neoplasm haematologic cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer myeloid proliferation and myeloid neoplasm cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-nail-topography"
        },
        "description": "The body location used to describe the point of origin for skin cancer of the nail or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer nail topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-nasal-paranasal-cancer-type"
        },
        "description": "The type of the primary nasal solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer nasal cavity and paranasal sinus cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-national-cervical-screening-benign-reactive-diagnosis"
        },
        "description": "The morphologic abnormality used to describe a benign or reactive diagnosis recorded within the National Cervical Screening Programme (NCSP).",
        "exampleBoolean": false,
        "name": "NZ cancer national cervical screening programme benign and reactive diagnosis"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-national-cervical-screening-excision-completeness"
        },
        "description": "The status on whether the excision was complete or not, which is recorded within the National Cervical Screening Programme (NCSP).",
        "exampleBoolean": false,
        "name": "NZ cancer national cervical screening programme completeness of excision"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-national-cervical-screening-specimen-type"
        },
        "description": "The type of specimen collected, which is recorded within the National Cervical Screening Programme (NCSP).",
        "exampleBoolean": false,
        "name": "NZ cancer national cervical screening programme specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-national-cervical-screening-topography"
        },
        "description": "The body location used to describe the point of origin for a cancer recorded within the National Cervical Screening Programme (NCSP).",
        "exampleBoolean": false,
        "name": "NZ cancer national cervical screening programme topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-neoadjuvant-therapy-type-non-hormone"
        },
        "description": "The type of neoadjuvant therapy that has been performed (excluding neoadjuvant hormone therapy) or an 'Unknown' value.",
        "exampleBoolean": false,
        "name": "NZ cancer neoadjuvant therapy administration type (non-hormone)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-neoadjuvant-therapy-response-system"
        },
        "description": "A scoring system system used to measure a patient's response to neoadjuvant therapy or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer neoadjuvant therapy response system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-neuroendocrine-gep-cancer-type"
        },
        "description": "The type of the primary neuroendocrine tumour gastroenteropancreatic (GEP) solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine GEP cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-neuroendocrine-non-gep-cancer-type"
        },
        "description": "The type of the primary neuroendocrine tumour non-gastroenteropancreatic (non-GEP) solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine non GEP cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-neuroendocrine-substream"
        },
        "description": "The subcategory of the primary neuroendocrine solid cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-net-breast-topography"
        },
        "description": "The body location used to describe the point of origin for a neuroendocrine tumour (NET) of the breast excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine tumour breast topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-net-male-genital-topography"
        },
        "description": "The body location used to describe the point of origin for a neuroendocrine tumour (NET) of the male genital system excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine tumour male genital topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-net-urinary-topography"
        },
        "description": "The body location used to describe the point of origin for a neuroendocrine tumour (NET) of the urinary system excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer neuroendocrine tumour urinary topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-non-hodgkin-lymphoma-cancer-type"
        },
        "description": "The type of non Hodgkin lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer non Hodgkin lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-non-ajcc-staging-system"
        },
        "description": "Non-AJCC staging systems that may be used to classify the stage of a cancer diagnosis or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer non-AJCC staging system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-not-performed-reason"
        },
        "description": "The reason why the procedure and/or test was not performed.",
        "exampleBoolean": false,
        "name": "NZ cancer not performed reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-nuclear-grade"
        },
        "description": "The grade of a breast cancer, assessed using the nuclear ductal carcinoma in situ grading system.",
        "exampleBoolean": false,
        "name": "NZ cancer nuclear grade of DCIS grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-observation"
        },
        "description": "Observable entities used to represent the meaning of CanShare data elements.",
        "exampleBoolean": false,
        "name": "NZ cancer observation code"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-hep-pan-bil-other-topography"
        },
        "description": "The body location used to describe the point of origin for hepatopancreaticobiliary cancer which is not a liver, biliary or pancreas primary or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer other gastrointestinal hepatopancreaticobiliary topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-parathryoid-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the parathyroid excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer parathryoid topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-ngs-pcr"
        },
        "description": "Test method procedures used in laboratory studies.",
        "exampleBoolean": false,
        "name": "NZ cancer PCR OR NGS test method"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-percist-1-cancer-burden"
        },
        "description": "The neoadjuvant therapy response score for solid tumours, defined using the PERCIST 1.0 cancer burden system.",
        "exampleBoolean": false,
        "name": "NZ cancer PERCIST 1.0 cancer burden"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-performance-status"
        },
        "description": "The performance status of the procedure and/or test.",
        "exampleBoolean": false,
        "name": "NZ cancer performance status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-pharynx-larynx-cancer-type"
        },
        "description": "The type of the primary pharynx and larynx and trachea solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer pharynx and larynx and trachea cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-pit-prognostic-score"
        },
        "description": "The prognostic score for T-cell lymphoma, defined using the Prognostic Index for T-cell Lymphoma (PIT) prognostic scoring system.",
        "exampleBoolean": false,
        "name": "NZ cancer PIT prognostic score"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-pituitary-net-topography"
        },
        "description": "The body location used to describe the point of origin for a neuroendocrine tumour of the pituitary gland excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer pituitary neuroendocrine tumour topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-polyp-morphology-specimen-type"
        },
        "description": "The type of polyp specimen (based on morphology) collected for a pathology request an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer polyp morphology specimen type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-specimen-polyp-profile"
        },
        "description": "The type of polyp profile on a specimen collected for a pathology request.",
        "exampleBoolean": false,
        "name": "NZ cancer polyp profile type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-pos-neg-result"
        },
        "description": "The result for a test (eg positive, negative), where more specific finding values are not available.",
        "exampleBoolean": false,
        "name": "NZ cancer positive negative result"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-presence-tumour-finding"
        },
        "description": "Presence of tumour findings in relation to prognostic factors of a cancer diagnosis.",
        "exampleBoolean": false,
        "name": "NZ cancer presence of tumour finding"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-referral-criteria-procedure-assessment"
        },
        "description": "The assessment for which the referral criteria for a procedure is established plus other value.",
        "exampleBoolean": false,
        "name": "NZ cancer procedure referral criteria assessment"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-procedure-status"
        },
        "description": "The status of a procedure.",
        "exampleBoolean": false,
        "name": "NZ cancer procedure status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-prognostic-scoring-system"
        },
        "description": "Systems that may be used to score the prognostic factors of a cancer diagnosis or an \"other value\".",
        "exampleBoolean": false,
        "name": "NZ cancer prognostic scoring system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-revised-multiple-myeloma-stage"
        },
        "description": "The stage groups for multiple myeloma, defined using Revised International Staging System (R-ISS).",
        "exampleBoolean": false,
        "name": "NZ cancer R-ISS for multiple myeloma stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ro-beam-energy-type"
        },
        "description": "The type of beam energy which is used plan and deliver the radiation therapy treatment.",
        "exampleBoolean": false,
        "name": "NZ cancer radiation oncology beam energy type"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-ro-fsa-priority"
        },
        "description": "A categorisation used to prioritise booking a first specialist assessment, for radiation oncology services.",
        "exampleBoolean": false,
        "name": "NZ cancer radiation oncology FSA prioritisation category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-ro-planning-technique"
        },
        "description": "The planning technique used to plan the radiation therapy treatment.",
        "exampleBoolean": false,
        "name": "NZ cancer radiation oncology planning technique"
      },
      {
        "reference": {
          "reference": "CodeSystem/canshare-ro-treatment-priority"
        },
        "description": "A categorisation used to prioritise the start of radiation therapy treatment.",
        "exampleBoolean": false,
        "name": "NZ cancer radiation oncology treatment prioritisation category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-radiology-type"
        },
        "description": "The types of radiology, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer radiology type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-rai-cll-stage"
        },
        "description": "The stage groups for chronic lymphocytic leukaemia, defined by Rai staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer Rai staging for CLL stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-recist-1-1-cancer-burden"
        },
        "description": "The neoadjuvant therapy response score for solid tumours, defined using the RECIST 1.1 cancer burden system.",
        "exampleBoolean": false,
        "name": "NZ cancer RECIST 1.1 cancer burden"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-recurrence-type"
        },
        "description": "The type of cancer recurrence, e.g. local, regional plus unknown and not applicable values.",
        "exampleBoolean": false,
        "name": "NZ cancer recurrence type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-revised-mayo-amyloidosis-stage"
        },
        "description": "The revised stage groups for amyloidosis, defined using Mayo 2012 staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer revised Mayo staging 2012 for AL (amyloidosis) stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-b-lymphoma-stage"
        },
        "description": "The revised stage groups for primary cutaneous T-cell lymphoma, defined using TNM-B category staging system.",
        "exampleBoolean": false,
        "name": "NZ cancer revised TNM-B staging for cutaneous T cell lymphoma stage"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-service"
        },
        "description": "The type of cancer service that is currently, or should in the future, treat this cancer.",
        "exampleBoolean": false,
        "name": "NZ cancer service"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-side"
        },
        "description": "The side of a body structure that is symmetrical to the midline, e.g. left side, right side, both sides or central.",
        "exampleBoolean": false,
        "name": "NZ cancer side"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-side-mandatory"
        },
        "description": "The side of a body structure that is symmetrical to the midline, e.g. left side, right side, both sides, central, or a 'definitely not present' value.",
        "exampleBoolean": false,
        "name": "NZ cancer side mandatory"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-simple-performance-status"
        },
        "description": "The simple performance status of the procedure and/or test i.e. performed or not performed.",
        "exampleBoolean": false,
        "name": "NZ cancer simple performance status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-melanoma-substream"
        },
        "description": "The subcategory of the primary skin and melanoma solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer skin and melanoma substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-cancer-type"
        },
        "description": "The type of the primary skin solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer skin cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-extremity-topography"
        },
        "description": "The body location used to describe the point of origin for skin cancer of the extremity or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer skin of extremity topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-head-neck-topography"
        },
        "description": "The body location used to describe the point of origin for skin cancer of the head and neck or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer skin of head and neck topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-trunk-topography"
        },
        "description": "The body location used to describe the point of origin for skin cancer of the trunk or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer skin of trunk topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-skin-topography"
        },
        "description": "The body location used to describe the point of origin for a skin cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer skin topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-abdomen-pelvis-topography"
        },
        "description": "The body location used to describe the point of origin for abdomen and pelvis soft tissue cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue abdomen and pelvis topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-bone-cancer-type"
        },
        "description": "The type of the primary soft tissue and bone solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue and bone cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-bone-substream"
        },
        "description": "The subcategory of the primary soft tissue and bone solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue and bone substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-extremity-topography"
        },
        "description": "The body location used to describe the point of origin for extremity soft tissue cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue extremity topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-head-neck-topography"
        },
        "description": "The body location used to describe the point of origin for head and neck soft tissue cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue head and neck topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-skin-topography"
        },
        "description": "The body location used to describe the point of origin for skin soft tissue cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue skin topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-soft-tissue-thoracic-topography"
        },
        "description": "The body location used to describe the point of origin for thoracic soft tissue cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer soft tissue thoracic topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-solid-tumour-non-ajcc-staging-system"
        },
        "description": "Non-AJCC staging systems that may be used to classify the stage of a solid tumour or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer solid tumour non-AJCC staging system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-solid-tumour-sact-cancer-type"
        },
        "description": "The type of the primary solid cancer being assessed and treated, by systemic anti-cancer therapy (SACT).",
        "exampleBoolean": false,
        "name": "NZ cancer solid tumour SACT cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-solid-tumour-staging-system"
        },
        "description": "Systems that may be used to classify the stage of a solid tumour or an \"other value\".",
        "exampleBoolean": false,
        "name": "NZ cancer solid tumour staging system"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-solid-tumour-substream"
        },
        "description": "The subcategory of the primary solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer solid tumour substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-specimen-category"
        },
        "description": "The category of specimen collected for a pathology request an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer specimen category"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-specimen-category-excision-biopsy"
        },
        "description": "Whether the category of specimen is a biopsy or an excision for a pathology request form.",
        "exampleBoolean": false,
        "name": "NZ cancer specimen category biopsy or excision"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-specimen-dimension-type"
        },
        "description": "The type of specimen dimension being observed.",
        "exampleBoolean": false,
        "name": "NZ cancer specimen dimension type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-stage-classification"
        },
        "description": "Stage classification used to define timing of staging.",
        "exampleBoolean": false,
        "name": "NZ cancer stage classification"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-cancer-stream"
        },
        "description": "The category of the primary cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer stream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-surgical-margin-proximal-distal"
        },
        "description": "An additional qualification of the margin description to confirm if margin is proximal or distal.",
        "exampleBoolean": false,
        "name": "NZ cancer surgical margin qualifier proximal or distal"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-surgical-margin-type"
        },
        "description": "The type of margin observed in a surgical cancer setting.",
        "exampleBoolean": false,
        "name": "NZ cancer surgical margin type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-t-nk-cell-lymphoma-cancer-type"
        },
        "description": "The type of T/NK cell lymphoma haematologic cancer being assessed and/or treated.",
        "exampleBoolean": false,
        "name": "NZ cancer T/NK cell lymphoma cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-test-failure-reason"
        },
        "description": "The reason why the test failed.",
        "exampleBoolean": false,
        "name": "NZ cancer test failure reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-test-inconclusive-reason"
        },
        "description": "The reason why the test result is inconclusive.",
        "exampleBoolean": false,
        "name": "NZ cancer test inconclusive reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thoracic-cancer-type"
        },
        "description": "The type of the primary thoracic solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer thoracic cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thorax-lung-lobe-topography"
        },
        "description": "The body location used to describe the lobe of the lung.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax lung lobe topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-thorax-lung"
        },
        "description": "Lymph nodes used for diagnosis of thoracic lung cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax lung lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-thorax"
        },
        "description": "Lymph nodes used for diagnosis of thoracic cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-thorax-mesothelioma-topography"
        },
        "description": "The body location used to describe the point of origin mesothelioma or an 'Other' value used for medical oncology treatment services.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax medical oncology mesothelioma topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-thorax-topography"
        },
        "description": "The body location used to describe the point of origin for thorax cancer or an 'Other' value used for medical oncology treatment services.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax medical oncology topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thorax-soft-tissue-topography"
        },
        "description": "The body location used to describe the point of origin for soft tissue sarcoma of thorax and mediastinum primary or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax soft tissue topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thorax-thymus-topography"
        },
        "description": "The body location used to describe the point of origin for thymus cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax thymus topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thorax-topography"
        },
        "description": "The body location used to describe the point of origin for thorax cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thorax topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thryoid-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the thyroid excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thryoid topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-thyroid-topography"
        },
        "description": "The body location used to describe the point of origin for cancer of the thyroid excluding lymph nodes or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer thyroid topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-treatment-intent"
        },
        "description": "Treatment intents or reasons for using a therapeutic procedure to treat cancer.",
        "exampleBoolean": false,
        "name": "NZ cancer treatment intent"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tumour-focality"
        },
        "description": "The focality of a tumour.",
        "exampleBoolean": false,
        "name": "NZ cancer tumour focality"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tumour-origin"
        },
        "description": "The suspected origin of the tumour clinically assessed.",
        "exampleBoolean": false,
        "name": "NZ cancer tumour origin"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-unknown-site-topography"
        },
        "description": "The unknown body location of a cancer.",
        "exampleBoolean": false,
        "name": "NZ cancer unknown site topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-upper-gastro-cancer-type"
        },
        "description": "The type of the primary upper gastrointestinal solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer upper gastrointestinal cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-gi-upper-topography"
        },
        "description": "The body location used to describe the point of origin for upper gastrointestinal cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer upper gastrointestinal topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-kidney"
        },
        "description": "Lymph nodes used for diagnosis of kidney cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital kidney lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-kidney-topography"
        },
        "description": "The body location used to describe the point of origin for kidney cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital kidney topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital"
        },
        "description": "Lymph nodes used for diagnosis of urinary and male genital cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-penis"
        },
        "description": "Lymph nodes used for diagnosis of penis cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital penis lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-prostate-topography"
        },
        "description": "The body location used to describe the point of origin for prostate cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital prostate topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis-ureter"
        },
        "description": "Lymph nodes used for diagnosis of renal pelvis and ureter cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital renal pelvis and ureter lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-renal-pelvis-ureter-topography"
        },
        "description": "The body location used to describe the point of origin for renal pelvis and ureter cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital renal pelvis and ureter topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-renal-pelvis"
        },
        "description": "Lymph nodes used for diagnosis of renal pelvis cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital renal pelvis lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-testicular-adnexa-topography"
        },
        "description": "The body location used to describe the point of origin for testicular adnexa cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital testicular adnexa topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-testicular-topography"
        },
        "description": "The body location used to describe the point of origin for testicular cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital testicular topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-testis"
        },
        "description": "Lymph nodes used for diagnosis of testis cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital testis lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-testis-topography"
        },
        "description": "The body location used to describe the point of origin for testis cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital testis topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary-male-genital-urinary-bladder"
        },
        "description": "Lymph nodes used for diagnosis of urinary bladder cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital urinary bladder lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-male-genital-urinary-bladder-topography"
        },
        "description": "The body location used to describe the point of origin for urinary bladder cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary and male genital urinary bladder topography"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-system-cancer-type"
        },
        "description": "The type of the primary urinary system solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary system cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lymphnode-urinary"
        },
        "description": "Lymph nodes used for diagnosis of urinary system cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary system lymph node"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-urinary-topography"
        },
        "description": "The body location used to describe the point of original for urinary system cancer or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ cancer urinary system topography"
      },
      {
        "reference": {
          "reference": "CodeSystem/citizenship-status"
        },
        "description": "Is this person a NZ Citizen",
        "exampleBoolean": false,
        "name": "NZ Citizenship status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-stage-clinical-classification"
        },
        "description": "TNM stage classification used to define timing of clinical staging.",
        "exampleBoolean": false,
        "name": "NZ clinical TNM stage classification"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-obstruction-perforation"
        },
        "description": "Whether there is obstruction or perforation of the colorectum.",
        "exampleBoolean": false,
        "name": "NZ colorectal obstruction or perforation present in colon"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-obstruction"
        },
        "description": "Whether or not obstruction of colorectum is or is not identified.",
        "exampleBoolean": false,
        "name": "NZ colorectal obstruction present"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-perforation"
        },
        "description": "Whether or not perforation of colorectum is or is not identified.",
        "exampleBoolean": false,
        "name": "NZ colorectal perforation present"
      },
      {
        "reference": {
          "reference": "ValueSet/ethnicgroupcodelevel1"
        },
        "description": "NZ Ethnicity level 1 codes only.",
        "exampleBoolean": false,
        "name": "NZ ethnic group code level 1"
      },
      {
        "reference": {
          "reference": "CodeSystem/Ethnicity"
        },
        "description": "A FHIR CodeSystem of Australian and Ethnicity New Zealand Standard Classification",
        "exampleBoolean": false,
        "name": "NZ ethnic group codes"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-lung-cancer-type"
        },
        "description": "The type of the primary lung solid cancer being assessed and treated.",
        "exampleBoolean": false,
        "name": "NZ lung cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-endocrine-neuroendocrine-cancer-type"
        },
        "description": "The type of the primary endocrine and neuroendocrine tumour solid cancer being assessed and treated by medical oncology services.",
        "exampleBoolean": false,
        "name": "NZ medical oncology cancer endocrine and neuroendocrine cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-mo-who-brain-primary-histology"
        },
        "description": "Histologies used for brain primaries by medical oncology services, from WHO Classification of Tumours, Central Nervous System Tumours (latest edition) - 2. Gliomas, glioneuronal tumours, and neuronal tumours, 3. Choroid plexus tumours, 4. Embyronal tumours, 5. Pineal tumours, 7. Meningioma, 8. Mesenchymal, non-meningothelial tumours involving the CNS, 9. Melanocytic tumours, 11. Germ cell tumours, 12. Tumours of the sellar region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ medical oncology WHO brain primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-nottingham-grade"
        },
        "description": "The grade of a breast cancer, assessed using the Nottingham combined grading system.",
        "exampleBoolean": false,
        "name": "NZ Nottingham Combined grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-colorectal-colon-perforation"
        },
        "description": "Whether or not perforation of colon is or is not identified.",
        "exampleBoolean": false,
        "name": "NZ perforation present in colon"
      },
      {
        "reference": {
          "reference": "CodeSystem/d1adf025-b6d2-44dc-a8b1-da3adfcafa73"
        },
        "description": "Additional codes to be incorporated with HL7 v3 Value Set Purpose of Use",
        "exampleBoolean": false,
        "name": "NZ Purpose Of Use"
      },
      {
        "reference": {
          "reference": "CodeSystem/nz-residency"
        },
        "description": "NZ Residency status",
        "exampleBoolean": false,
        "name": "NZ Residency status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-aml-disease-response"
        },
        "description": "Types of responses to an acute myeloid leukaemia systemic anti-cancer therapy (SACT) treament.",
        "exampleBoolean": false,
        "name": "NZ SACT acute myeloid leukemia disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-amyloidosis-disease-response"
        },
        "description": "Types of responses to an amyloidosis systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT amyloidosis disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-cancer-type"
        },
        "description": "The type of primary cancer being assessed, by medical oncology and heamatology services",
        "exampleBoolean": false,
        "name": "NZ SACT cancer type"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-cll-sll-disease-response"
        },
        "description": "Types of responses to a chronic lymphocytic leukaemia and small lymphocytic lymphoma systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT chronic lymphocytic leukemia and small lymphocytic lymphoma disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-cml-disease-response"
        },
        "description": "Types of responses to a chronic myeloid leukaemia systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT chronic myeloid leukemia disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-dose-form"
        },
        "description": "Dose forms in which a systemic anti-cancer therapy (SACT) medication may be prescribed or administered.",
        "exampleBoolean": false,
        "name": "NZ SACT dose form"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-dose-unit"
        },
        "description": "Units that may be used to describe the dose of a systemic anti-cancer therapy (SACT) medication.",
        "exampleBoolean": false,
        "name": "NZ SACT dose unit"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-ecog-status"
        },
        "description": "The performance status of a patient as defined by the Eastern Cooperative Oncology Group (ECOG) minus ECOG 5 (A performance status used when a patient is \"Dead\").",
        "exampleBoolean": false,
        "name": "NZ SACT ECOG status"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-haem-disease-response"
        },
        "description": "Types of responses to a haematological systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT haematology disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-heam-disease-response"
        },
        "description": "Types of responses to a heamatological systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT heamatology disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-non-small-lymphocytic-disease-response"
        },
        "description": "Types of responses to a non small lymphocytic systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT lymphoma (non small lymphocytic) disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-mo-disease-response"
        },
        "description": "Types of responses to a medical oncology systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT medical oncology disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-mds-disease-response"
        },
        "description": "Types of responses to a myelodysplastic syndrome systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ SACT myelodysplastic syndrome disease response"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-overall-discontinue-reason"
        },
        "description": "Overall reasons that a systemic anti-cancer therapy (SACT) regimen may be discontinued plus other value.",
        "exampleBoolean": false,
        "name": "NZ SACT overall discontinue reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-patient-factor-discontinue-reason"
        },
        "description": "Patient factors that may result in the discontinuation of a systemic anti-cancer therapy (SACT) treatment plus not asked value.",
        "exampleBoolean": false,
        "name": "NZ SACT patient factor discontinue"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-pr-expression"
        },
        "description": "A diagnosis of whether or not a tumour is progesterone receptive (PR) minus inconculsive value.",
        "exampleBoolean": false,
        "name": "NZ SACT PR expression"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-surgical-intent"
        },
        "description": "The purpose of the surgical procedure.",
        "exampleBoolean": false,
        "name": "NZ surgical intent"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-toxicity-discontinue-reason"
        },
        "description": "Toxicity factors that may result in the discontinuation of a systemic anti-cancer therapy (SACT) treatment.",
        "exampleBoolean": false,
        "name": "NZ systemic anti-cancer therapy toxicity discontinue reason"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-sact-cancer-substream"
        },
        "description": "The subcategory of the primary cancer being assessed and treated by medical oncology and heamatology services.",
        "exampleBoolean": false,
        "name": "NZ systemtic anti-cancer therapy substream"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-stage-classification"
        },
        "description": "TNM stage classification used to define timing of staging.",
        "exampleBoolean": false,
        "name": "NZ TNM stage classification"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-tnm-suffix"
        },
        "description": "The suffix added to the TNM category.",
        "exampleBoolean": false,
        "name": "NZ TNM suffix"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-differentiation-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) malignant differentiation grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO (5th edition) malignant differentiation grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-low-high-diff-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) malignant low / high (differentiation) grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO (5th edition) malignant low high (differentiation) grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-neuroendocrine-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours (5th edition) atypical or typical neuroendocrine tumour grading system for thoracic tumours.",
        "exampleBoolean": false,
        "name": "NZ WHO (5th edition) thoracic neuroendocrine tumour grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-anus-primary-histology"
        },
        "description": "Histologies used for anal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 7. Tumours of the anal canal,12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO anus primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-appendix-site-histology"
        },
        "description": "Histologies used for appendix neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix,11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO appendix site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-bone-haematolymphoid-histology"
        },
        "description": "Histologies used for bone haematolymphoid cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 4. Bone tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO bone haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-bone-histology"
        },
        "description": "Histologies used for bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 4. Bone tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO bone histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-bone-histology"
        },
        "description": "Histologies used for bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, 5th edition - 4. Bone tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO bone histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-brain-primary-histology"
        },
        "description": "Histologies used for brain primaries, from WHO Classification of Tumours, Central Nervous System Tumours (latest edition) - 2. Gliomas, glioneuronal tumours, and neuronal tumours, 3. Choroid plexus tumours, 4. Embyronal tumours, 5. Pineal tumours, 7. Meningioma, 8. Mesenchymal, non-meningothelial tumours involving the CNS, 9. Melanocytic tumours, 11. Germ cell tumours, 12. Tumours of the sellar region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO brain primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-brain-site-histology"
        },
        "description": "Histologies used for brain sites, from WHO Classification of Tumours, Central Nervous System Tumours (latest edition) - 2. Gliomas, glioneuronal tumours, and neuronal tumours, 3. Choroid plexus tumours, 4. Embyronal tumours, 5. Pineal tumours, 7. Meningioma, 8. Mesenchymal, non-meningothelial tumours involving the CNS, 9. Melanocytic tumours, 10. Haematolymphoid tumours involving the CNS, 11. Germ cell tumours, 12. Tumours of the sellar region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO brain site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-breast-behaviour-free-histology"
        },
        "description": "Histologies used for behaviour free breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast behaviour free histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-breast-benign-histology"
        },
        "description": "Histologies used for benign breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast benign histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-in-situ-carcinoma-histology"
        },
        "description": "Histologies used for in situ carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast ductal carcinoma in situ histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-haematolymphoid-histology"
        },
        "description": "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 6. Haematolymphoid tumours of the breast) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-breast-haematolymphoid-histology"
        },
        "description": "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 6. Haematolymphoid tumours of the breast) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-breast-histology"
        },
        "description": "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-invasive-carcinoma-histology"
        },
        "description": "Histologies used for invasive carcinoma breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast invasive carcinoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-invasive-histology"
        },
        "description": "Histologies used for invasive breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast invasive histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-primary-histology"
        },
        "description": "Histologies used for breast primaries (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 2. Epithelial tumours of the breast, 3. Fibroepithelial tumours and hamartomas of the breast, 4. Tumours of the nipple, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-nipple-histology"
        },
        "description": "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition - 4. Tumours of the nipple) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast tumour of nipple histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-breast-nipple-histology"
        },
        "description": "Histologies used for breast cancer types (WHO Classification of Tumours, Breast Tumours, 5th edition - 4. Tumours of the nipple) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast tumour of nipple histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-breast-uncertain-borderline-histology"
        },
        "description": "Histologies used for uncertain and borderline breast cancer types (WHO Classification of Tumours, Breast Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO breast uncertain and borderline histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-choroid-plexus-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 3. Choroid plexus tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system choroid plexus histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-cranial-paraspinal-nerve-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 6. Cranial and paraspinal nerve tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system cranial and paraspinal nerve histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-cranial-paraspinal-nerve-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 6. Cranial and paraspinal nerve tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system cranial and paraspinal nerve histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-embryonal-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 4. Embryonal tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system embryonal histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-germ-cell-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 11. Germ cell tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system germ cell histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-glioma-glioneuronal-neuronal-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 2. Gliomas, glioneuronal tumours, and neuronal tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system glioma and glioneuronal and neuronal histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-haematolymphoid-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 10. Haematolymphoid tumours involving the CNS) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-haematolymphoid-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 10. Haematolymphoid tumours involving the CNS) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-melanocytic-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 9. Melanocytic tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system melanocytic histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-meningioma-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 7. Meningioma) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system meningioma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-pineal-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 5. Pineal tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system pineal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-pineal-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 5. Pineal tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system pineal histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-sellar-region-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, latest edition - 12. Tumours of the sellar region) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system sellar region histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-cns-sellar-region-histology"
        },
        "description": "Histologies used for central nervous system cancer types (WHO Classification of Tumours, Central Nervous System Tumours, 5th edition - 12. Tumours of the sellar region) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system sellar region histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-cns-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours central nervous system tumour grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO central nervous system tumour grade reference set"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-melanoma-cns-primary-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, section Ocular and CNS melanocytic tumours, latest edition, excluding Ocular and benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of CNS melanoma primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-melanoma-primary-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, latest edition, excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of melanoma primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-merkel-primary-histology"
        },
        "description": "Histologies used for skin cancer types (WHO Classification of Tumours, Skin Tumours, latest edition, Chapter 2: keratinocytic/epidermal tumours, section Merkel cell carcinoma) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of Merkel cell carcinoma primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-squamous-primary-histology"
        },
        "description": "Histologies used for skin cancer types (WHO Classification of Tumours, Skin Tumours, latest edition, Chapter 2: keratinocytic/epidermal tumours, section squamous cell carcinoma) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of squamous cell carcinoma primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-melanoma-cns-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, section Ocular and CNS melanocytic tumours, 5th edition, excluding Ocular and benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) CNS melanoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-intest-nk-t-cell-lymphoid-histology"
        },
        "description": "Histologies used for intestinal T-cell and natural killer cell lymphoid proliferation (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-myeloid-secondary-histology"
        },
        "description": "Histologies used for secondary myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) haematolymphoid secondary myeloid neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-benign-histology"
        },
        "description": "Histologies used for head and neck benign cancer types (WHO Classification of Tumours, Head and Neck Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck benign histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-ear-histology"
        },
        "description": "Histologies used for head and neck cancer types, ear tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 8: Ear tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck ear histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-haematolymphoid-histology"
        },
        "description": "Histologies used for head and neck cancer types, haematolymphoid proliferations and neoplasia (WHO Classification of Tumours, Head and Neck Tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-histology"
        },
        "description": "Histologies used for head and neck cancer types (WHO Classification of Tumours, Head and Neck Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-pharynx-larynx-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck hypopharynx and larynx and trachea and parapharyngeal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-malignant-histology"
        },
        "description": "Histologies used for head and neck malignant cancer types (WHO Classification of Tumours, Head and Neck Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck malignant histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-melanocytic-histology"
        },
        "description": "Histologies used for head and neck cancer types, melanocytic tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 11: Melanocytic tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck melanocytic histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-nasal-skull-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck nasal and paranasal and skull base histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-nasopharynx-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasopharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 2: Nasopharyngeal tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck nasopharynx histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-odontogenic-maxfac-histology"
        },
        "description": "Histologies used for head and neck cancer types, odontogenic and maxillofacial bone tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 7: Odontogenic and maxillofacial bone tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck odontogenic and maxillofacial bone histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-oral-cavity-histology"
        },
        "description": "Histologies used for head and neck cancer types, oral cavity and mobile tongue tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 5: Oral cavity and mobile tongue tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck oral cavity and mobile tongue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-precursor-histology"
        },
        "description": "Histologies used for head and neck precursor cancer types (WHO Classification of Tumours, Head and Neck Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck precursor histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-salivary-histology"
        },
        "description": "Histologies used for head and neck cancer types, salivary gland tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 4: Salivary gland tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck salivary gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-soft-tissue-histology"
        },
        "description": "Histologies used for head and neck cancer types, soft tissue tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 9: Soft tissue tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck soft tissue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-head-neck-neck-lymph-histology"
        },
        "description": "Histologies used for head and neck cancer types, tumours and tumour-like lesions of the neck and lymph nodes (WHO Classification of Tumours, Head and Neck Tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) head and neck tumour and tumour-like lesion of the neck and lymph node histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-melanoma-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, 5th edition, excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) melanoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-merkel-histology"
        },
        "description": "Histologies used for skin cancer types (WHO Classification of Tumours, Skin Tumours, 5th edition, Chapter 2: keratinocytic/epidermal tumours, section Merkel cell carcinoma) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) Merkel cell carcinoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-melanoma-mucosal-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, section Mucosal melanomas, 5th edition, excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) mucosal melanoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-heamatolymphoid-histology"
        },
        "description": "Histologies used for skin haematolymphoid cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 6: Tumours of haematopoietic and lymphoid origin, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) skin haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-histology"
        },
        "description": "Histologies used for skin cancer types (WHO Classification of Tumours, Skin Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) skin histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-keratinocytic-epidermal-histology"
        },
        "description": "Histologies used for skin keratinocytic and epidermal cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 2: keratinocytic/epidermal tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) skin keratinocytic and epidermal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-precursor-histology"
        },
        "description": "Histologies used for skin precursor cancer types (WHO Classification of Tumours, Skin Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) skin precursor histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-skin-soft-tissue-histology"
        },
        "description": "Histologies used for skin soft tissue cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 7: Soft tissue tumours 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours (5th edition) skin soft tissue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-intestinal-nk-t-cell-lymphoid-histology"
        },
        "description": "Histologies used for intestinal T-cell and natural killer cell lymphoid proliferation (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours haematolymphoid intestinal T-cell and natural killer cell lymphoid proliferation histology reference set"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-myeloid-secondary-histology"
        },
        "description": "Histologies used for secondary myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours haematolymphoid secondary myeloid neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-benign-histology"
        },
        "description": "Histologies used for head and neck benign cancer types (WHO Classification of Tumours, Head and Neck Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck benign histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-ear-histology"
        },
        "description": "Histologies used for head and neck cancer types, ear tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 8: Ear tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck ear histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-germ-cell-histology"
        },
        "description": "Histologies used for head and neck cancer types, germ cell tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 13: Germ cell tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck germ cell tumour histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-haematolymphoid-histology"
        },
        "description": "Histologies used for head and neck cancer types, haematolymphoid proliferations and neoplasia (WHO Classification of Tumours, Head and Neck Tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes excluding benign neoplasms ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-hyp-lyx-trach-pps-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck hypopharynx and larynx and trachea and parapharyngeal site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-malignant-histology"
        },
        "description": "Histologies used for head and neck malignant cancer types (WHO Classification of Tumours, Head and Neck Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck malignant histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-melanocytic-histology"
        },
        "description": "Histologies used for head and neck cancer types, melanocytic tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 11: Melanocytic tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck melanocytic histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasal-skull-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasal and paranasal and skull base histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasal-skull-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, Chapter 9: Soft tissue tumours, Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasal and paranasal and skull base primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasal-skull-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasal and paranasal and skull base site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasal-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, Chapter 2: Nasopharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasal primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasal-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasal, paranasal, and skull base tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 1: Nasal, paranasal, and skull base tumours, Chapter 2: Nasopharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasal site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasopharynx-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasopharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 2: Nasopharyngeal tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasopharynx histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-nasopharynx-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, nasopharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 2: Nasopharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck nasopharynx site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-neuro-paragang-histology"
        },
        "description": "Histologies used for head and neck cancer types, neuroendocrine neoplasms and paraganglioma (WHO Classification of Tumours, Head and Neck Tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck neuroendocrine neoplasm and paraganglioma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-odontogenic-maxfac-histology"
        },
        "description": "Histologies used for head and neck cancer types, odontogenic and maxillofacial bone tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 7: Odontogenic and maxillofacial bone tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-odontogenic-maxfac-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, odontogenic and maxillofacial bone tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 7: Odontogenic and maxillofacial bone tumours, Chapter 9: Soft tissue tumours, & Chapter 15: Neuroendocrine neoplasms and paraganglioma excluding benign neoplasms excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck odontogenic and maxillofacial bone primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-oral-cavity-histology"
        },
        "description": "Histologies used for head and neck cancer types, oral cavity and mobile tongue tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 5: Oral cavity and mobile tongue tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck oral cavity and mobile tongue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-oral-cavity-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, oral cavity and mobile tongue tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 5: Oral cavity and mobile tongue tumours, Chapter 9: Soft tissue tumours Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma excluding benign neoplasms ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck oral cavity and mobile tongue primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-oropharynx-histology"
        },
        "description": "Histologies used for head and neck cancer types, oropharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 6: Oropharyngeal tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck oropharynx histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-oropharynx-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, oropharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 6: Oropharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck oropharynx primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, Chapter 2: Nasopharyngeal tumours, Chapter 6: Oropharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck pharynx and larynx and trachea primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-pharynx-larynx-trachea-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 3: Hypopharyngeal, laryngeal, tracheal, and parapharyngeal tumours, Chapter 2: Nasopharyngeal tumours, Chapter 6: Oropharyngeal tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma, Chapter 11: Melanocytic tumours, Chapter 12: Tumours and tumour-like lesions of the neck and lymph nodes) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck pharynx and larynx and trachea site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-salivary-histology"
        },
        "description": "Histologies used for head and neck cancer types, salivary gland tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 4: Salivary gland tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck salivary gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-salivary-primary-histology"
        },
        "description": "Histologies used for head and neck cancer types, salivary gland tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 4: Salivary gland tumours,Chapter 9: Soft tissue tumours, Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma excluding benign neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck salivary gland primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-salivary-site-histology"
        },
        "description": "Histologies used for head and neck cancer types, salivary gland tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 4: Salivary gland tumours, Chapter 9: Soft tissue tumours, Chapter 10: Haematolymphoid proliferations and neoplasia, Chapter 11: Melanocytic tumours, Chapter 13: Germ cell tumours, Chapter 15: Neuroendocrine neoplasms and paraganglioma or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck salivary gland site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-soft-tissue-histology"
        },
        "description": "Histologies used for head and neck cancer types, soft tissue tumours (WHO Classification of Tumours, Head and Neck Tumours, Chapter 9: Soft tissue tumours, ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck soft tissue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-head-neck-uncertain-histology"
        },
        "description": "Histologies used for head and neck uncertain behaviour cancer types (WHO Classification of Tumours, Head and Neck Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours head and neck uncertain behaviour histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-heamatolymphoid-histology"
        },
        "description": "Histologies used for skin haematolymphoid cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 6: Tumours of haematopoietic and lymphoid origin, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours skin haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-keratinocytic-epidermal-histology"
        },
        "description": "Histologies used for skin keratinocytic and epidermal cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 2: keratinocytic/epidermal tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours skin keratinocytic and epidermal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-malignant-histology"
        },
        "description": "Histologies used for skin cancer malignant types (WHO Classification of Tumours, Skin Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours skin malignant histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-melanocytic-histology"
        },
        "description": "Histologies used for skin melanocytic cancer types (WHO Classification of Tumours, Skin Tumours, Chapter 3: Melanocytic neoplasms, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours skin melanocytic neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-skin-precursor-histology"
        },
        "description": "Histologies used for skin precursor cancer types (WHO Classification of Tumours, Skin Tumours, , latest edition ) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO classification of tumours skin precursor histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-colorectal-primary-histology"
        },
        "description": "Histologies used for colorectal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 6. Tumours of the colon and rectum, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO colorectal primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-colorectal-site-histology"
        },
        "description": "Histologies used for colorectal neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 6. Tumours of the colon and rectum, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO colorectal site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-conjunctiva-primary-histology"
        },
        "description": "Histologies used for conjunctiva primaries, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 2. Tumours of the conjunctiva and caruncle, 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO conjunctiva primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-anal-canal-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 7. Tumours of the anal canal or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system anal canal histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-appendix-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 5. Tumours of the appendix or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system appendix histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-appendix-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 5. Tumours of the appendix or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system appendix histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-benign-histology"
        },
        "description": "Histologies used for digestive system benign cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system benign tumour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-colon-rectum-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 6. Tumours of the colon and rectum or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system colon and rectum histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-colon-rectum-hormone-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 6. Tumours of the colon and rectum. Neuroendocrine tumour hormone producing subtype or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system colon and rectum hormone producing tumor histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-germ-tumour-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 13. Other digestive system, germ cell tumour or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system germ cell tumour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-haematolymphoid-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 11. Haematolymphoid tumours of the digestive system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-liver-intrahepatic-bile-duct-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 8. Tumours of the liver and intrahepatic bile ducts or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system liver and intrahepatic bile duct histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-malignant-histology"
        },
        "description": "Histologies used for digestive system malignant cancer types (WHO Classification of Tumours, Digestive System Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system malignant tumour histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-mesenchymal-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 12. Mesenchymal tumours of the digestive system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system mesenchymal histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-mesenchymal-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) 12. Mesenchymal tumours of the digestive system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system mesenchymal histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-oesophagus-histology"
        },
        "description": "Histologies used for digestive system cancer types (WHO Classification of Tumours, Digestive System Tumours, latest edition) 2. Tumours of the oesophagus or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system oesophagus histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-precursor-histology"
        },
        "description": "Histologies used for digestive system precursor cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system precursor tumour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-digestive-uncertain-histology"
        },
        "description": "Histologies used for digestive system uncertani behaviour cancer types (WHO Classification of Tumours, Digestive System Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system uncertain behaviour tumour histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-digestive-uncertain-histology"
        },
        "description": "Histologies used for digestive system uncertani behaviour cancer types (WHO Classification of Tumours, Digestive System Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO digestive system uncertain behaviour tumour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 5. Adrenal gland tumours 9. Mesenchymal and stromal tumours and 11. Germ cell tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal cortex primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-site-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 5. Adrenal gland tumours 9. Mesenchymal and stromal tumours, 10. Haematolymphoid tumours and 11. Germ cell tumours .or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal cortex site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-cortex-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 5. Adrenal gland tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-adrenal-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 5. Adrenal gland tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal gland histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 5. Adrenal gland tumours, 6. Adrenal medulla and extra-adrenal paraganglia tumours 9. Mesenchymal and stromal tumours and 11. Germ cell tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-site-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition)5. Adrenal gland tumours, 6. Adrenal medulla and extra-adrenal paraganglia tumours 9. Mesenchymal and stromal tumours, 10. Haematolymphoid tumours and 11. Germ cell tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal gland including adrenal medulla site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-adrenal-medulla-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine adrenal medulla cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 6. Adrenal medulla and extra-adrenal paraganglia tumours (excluding paraganglioma) 8. Neuroendocrine neoplasms in non-endocrine organs excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine adrenal medulla primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-benign-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine benign cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine benign histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-germ-cell-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 11. Germ cell tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine germ cell histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-malignant-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine malignant cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine malignant histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-malignant-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine malignant cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine malignant histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-paraganglioma-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine adrenal medulla cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 6. Adrenal medulla and extra-adrenal paraganglia tumours (Paraganglioma and Composite paraganglion tumours). 8. Neuroendocrine neoplasms in non-endocrine organs (Paraganglioma-like neuroendocrine neoplasms) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine paraganglioma primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-parathyroid-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 4. Parathyroid tumours 9. Mesenchymal and stromal tumours and 11. Germ cell tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine parathyroid gland primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-parathyroid-site-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 4. Parathyroid tumours 9. Mesenchymal and stromal tumours, 10. Haematolymphoid tumours and 11. Germ cell tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine parathyroid gland site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-pituitary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 2. Pituitary tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine pituitary gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-pituitary-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 2. Pituitary tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine pituitary gland histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-primary-pituitary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 2. Pituitary tumours value, 9. Mesenchymal and stromal tumours, 10. Haematolymphoid tumours, 11: Germ cell tumours excluding benign neoplasms or an 'Other'.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine pituitary gland primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-thyroid-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 3. Thyroid tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine thyroid gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-thyroid-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 3. Thyroid tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine thyroid gland histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-thyroid-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) including sections 3. Thyroid tumours, 9. Mesenchymal and stromal tumours, 11. Germ cell tumours benign neoplasms, or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine thyroid gland primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-uncertain-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine uncertain behaviour cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine uncertain behaviour histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-uncertain-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine uncertain behaviour cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine and neuroendocrine uncertain behaviour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-primary-histology"
        },
        "description": "Histologies used for endocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 2.pituitary tumours, 3. Thyroid tumours, 4. Parathyroid tumours, 5. Adrenal gland tumours, 6. Adrenal medulla and extra-adrenal paraganglia tumours, 9. Mesenchymal and stromal tumours, 11: Germ cell tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO endocrine primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-behaviour-free-histology"
        },
        "description": "Histologies used for behaviour free eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit behaviour free histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-eyelid-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 3. Tumours of the eyelid) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit eyelid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-haematolymphoid-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 10. Haematolymphoid tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-haematolymphoid-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 10. Haematolymphoid tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-in-situ-histology"
        },
        "description": "Histologies used for in situ eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit in situ histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-lacrimal-gland-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 7. Tumours of the lacrimal gland) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit lacrimal gland histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-lacrimal-gland-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 7. Tumours of the lacrimal gland) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit lacrimal gland histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-optic-disc-nerve-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 6. Tumours of the optic disc and optic nerve) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit optic disc and optic nerve histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-optic-disc-nerve-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 6. Tumours of the optic disc and optic nerve) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit optic disc and optic nerve histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-retina-neuroepithelium-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 5. Tumours of the retina and neuroepithelium) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit retina and neuroepithelium histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-soft-tissue-bone-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 11. Soft tissue and bone tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit soft tissue and bone histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-eye-orbit-uncertain-borderline-histology"
        },
        "description": "Histologies used for uncertain and borderline eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit uncertain and borderline histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eye-orbit-uveal-tract-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 4. Tumours of the uveal tract) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eye and orbit uveal tract histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-eyelid-site-histology"
        },
        "description": "Histologies used for eyelid sites, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 3. Tumours of the eyelid, 10. Haematolymphoid tumours, 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO eyelid site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-fallopian-tube-primary-histology"
        },
        "description": "Histologies used for fallopian tube primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 5. Tumours of the fallopian tube, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO fallopian tube primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-breast-primary-minus-nipple-histology"
        },
        "description": "Histologies used for female breast primaries, except for the nipple (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 2. Epithelial tumours of the breast, 3. Fibroepithelial tumours and hamartomas of the breast, 5. Mesenchymal tumours of the breast or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female breast primary (no nipple) histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-germ-cell-histology"
        },
        "description": "Histologies used for female genital germ cell tumours (WHO Classification of Tumours, Female Genital Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital germ cell histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-gestational-trophoblastic-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 8. Gestational trophoblastic disease) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital gestational trophoblastic disease histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-haematolymphoid-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 13. Haematolymphoid proliferations and neoplasia) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-haematolymphoid-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 13. Haematolymphoid proliferations and neoplasia) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-melanocytic-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 15. Melanocytic lesions) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital melanocytic lesion histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-mesenchymal-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 14. Mesenchymal tumours of lower genital tract) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital mesenchymal tumour of lower genital tract histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-neuroendocrine-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 12. Neuroendocrine neoplasia) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital neuroendocrine histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-neuroendocrine-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 12. Neuroendocrine neoplasia) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital neuroendocrine histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-ovary-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 2. Tumours of the ovary) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital ovary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-ovary-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 2. Tumours of the ovary) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital ovary histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-peritoneum-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 4. Tumours of the peritoneum) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital peritoneum histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-peritoneum-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 4. Tumours of the peritoneum) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital peritoneum histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-uterine-ligament-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 6. Tumours of the broad ligament and other uterine ligaments or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital uterine ligament histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-vagina-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 10. Tumours of the vagina) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital vagina histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-female-genital-vagina-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, 5th edition - 10. Tumours of the vagina) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital vagina histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-female-genital-vulva-histology"
        },
        "description": "Histologies used for female genital cancer types (WHO Classification of Tumours, Female Genital Tumours, latest edition - 11. Tumours of the vulva) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO female genital vulva histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-gestational-trophoblastic-site-histology"
        },
        "description": "Histologies used for gestational trophoblastic sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 8. Gestational trophoblastic disease, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO gestational trophoblastic site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-myeloproliferative-neoplasm-histology"
        },
        "description": "Histologies used for chronic myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematology chronic myeloproliferative neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-myeloproliferative-neoplasm-histology"
        },
        "description": "Histologies used for chronic myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th editions) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematology chronic myeloproliferative neoplasm histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-acute-leukaemia-amb-lineage-histology"
        },
        "description": "Histologies used for acute leukaemia of mixed or ambiguous lineage (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid acute leukaemia of mixed or ambiguous lineage histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-all-histology"
        },
        "description": "Histologies used for acute lymphoblastic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid acute lymphoblastic leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-aggressive-bcell-lymphoma-histology"
        },
        "description": "Histologies used for aggressive B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid aggressive cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-aggressive-nh-bcell-lymphoma-histology"
        },
        "description": "Histologies used for aggressive non-hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid aggressive non-hodgkin B cell lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-aggressive-nh-bcell-lymphoma-histology"
        },
        "description": "Histologies used for aggressive non-Hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid aggressive non-Hodgkin B cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-amyloidosis-histology"
        },
        "description": "Histologies used for amyloidosis (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid amyloidosis histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-b-cell-lymphoid-histology"
        },
        "description": "Histologies used for B-cell lymphoid neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) which are not Castleman disease, Acute lymphoblastic leukaemia, Indolent non-Hodgkin B cell lymphoma, Aggressive non-Hodgkin B cell lymphoma, Hodgkin lymphoma or Plasma cell disorders or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid B cell lymphoid neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-b-cell-lymphoma-histology"
        },
        "description": "Histologies used for B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid B cell lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-b-cell-lymphoma-histology"
        },
        "description": "Histologies used for B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid B cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-all-bcell-histology"
        },
        "description": "Histologies used for B lymphoblastic leukaemia lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid B lymphoblastic leukaemia lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-bl-histology"
        },
        "description": "Histologies used for Burkitt lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid Burkitt lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-bl-histology"
        },
        "description": "Histologies used for Burkitt lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid Burkitt lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-castleman-disorder-histology"
        },
        "description": "Histologies used for Castleman disease (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid Castleman disease histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-castleman-disorder-histology"
        },
        "description": "Histologies used for Castleman disease (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid Castleman disease histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-chronic-leukaemia-histology"
        },
        "description": "Histologies used for chronic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-histology-cll-histology"
        },
        "description": "Histologies used for chronic lymphocytic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic lymphocytic leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-histology-cll-histology"
        },
        "description": "Histologies used for chronic lymphocytic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic lymphocytic leukaemia histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-cml-histology"
        },
        "description": "Histologies used for chronic myeloid leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic myeloid leukaemia histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-cmml-histology"
        },
        "description": "Histologies used for chronic myelomonocytic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic myelomonocytic leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-cnl-histology"
        },
        "description": "Histologies used for chronic neutrophilic leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid chronic neutrophilic leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-et-histology"
        },
        "description": "Histologies used for essential thrombocythemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid essential thrombocythaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-et-histology"
        },
        "description": "Histologies used for essential thrombocythemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid essential thrombocythaemia histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoid-histology"
        },
        "description": "Histologies used for Epstein-Barr virus positive T-cell and natural killer cell lymphoiod proliferation (WHO Classification of Tumours, Haematolymphoid Tumours,latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid extranodal NK/T cell lymphoid proliferation histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-extranod-nk-t-cell-lymphoma-histology"
        },
        "description": "Histologies used for extranodal NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-extranod-nk-t-cell-lymphoma-histology"
        },
        "description": "Histologies used for extranodal NK cell and T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid extranodal NK/T cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-hcl-histology"
        },
        "description": "Histologies used for hairy cell leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid hairy cell leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-histiocytic-histology"
        },
        "description": "Histologies used for histiocytic and dendritic cell neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition - 3. Histiocytic/Dendritic cell neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid histiocytic dendritic cell neoplasm histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-histiocytic-other-histology"
        },
        "description": "Histologies used for histiocytic and dendritic cell neoplasms not dendritic cell or blastic plasmacytoid dendritic cell (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid histiocytic dendritic cell neoplasm other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-indolent-bcell-lymphoma-histology"
        },
        "description": "Histologies used for indolent B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid indolent B cell lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-indolent-bcell-lymphoma-histology"
        },
        "description": "Histologies used for indolent B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid indolent B cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-indolent-b-cell-lymphoma-other-histology"
        },
        "description": "Histologies used for other indolent B cell lymphoma not Chronic lymphocytic leukaemia and small lymphocytic lymphoma, Monoclonal B cell lymphocytosis, Hairy cell leukaemia, Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia), Marginal zone lymphoma or Follicular lymphoma or Mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid indolent B cell lymphoma other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-indolent-nh-bcell-lymphoma-histology"
        },
        "description": "Histologies used for indolent non-Hodgkin B cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid indolent non-Hodgkin B cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-indolent-nh-b-cell-lymphoma-other-histology"
        },
        "description": "Histologies used for other indolent non-hodgkin B cell lymphoma not Chronic lymphocytic leukaemia and/or small lymphocytic lymphoma, Monoclonal B cell lymphocytosis, Hairy cell leukaemia, Lymphoplasmacytic lymphoma (Waldenstrom macroglobulinaemia), Marginal zone lymphoma or Follicular lymphoma\nMantle cell lymphoma(WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid indolent non-hodgkin B cell lymphoma other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-leukaemia-histology"
        },
        "description": "Histologies used for leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-leukaemia-histology"
        },
        "description": "Histologies used for leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid leukaemia histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-lymphoma-not-sll-histology"
        },
        "description": "Histologies used for lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) excluding samll lymphocytic disease or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid lymphoma excluding small lymphocytic disease histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-lymphoplasmacytic-lymphoma-histology"
        },
        "description": "Histologies used for lymphoplasmacytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-lymphoplasmacytic-lymphoma-histology"
        },
        "description": "Histologies used for lymphoplasmacytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid lymphoplasmacytic lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mc-lymphoma-histology"
        },
        "description": "Histologies used for mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mantle cell lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-mc-lymphoma-histology"
        },
        "description": "Histologies used for mantle cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mantle cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mzl-histology"
        },
        "description": "Histologies used for marginal zone lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid marginal zone lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mast-cell-sarcoma-histology"
        },
        "description": "Histologies used for mast cell sarcoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mast cell sarcoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mastocytosis-other-histology"
        },
        "description": "Histologies used for mastocytosis which are not systemic or cutaneous or mast cell sarcoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mastocytosis other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-mature-tnk-leukaemia-histology"
        },
        "description": "Histologies used for mature T cell and natural killer cell leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-mature-tnk-leukaemia-histology"
        },
        "description": "Histologies used for mature T cell and natural killer cell leukaemia (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mature T cell and natural killer cell leukeamia histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-mature-tnk-cell-histology"
        },
        "description": "Histologies used for mature T cell and natural killer cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mature T cell and natural killer cell neoplasm histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-mature-tnk-cell-other-histology"
        },
        "description": "Histologies used for mature T-cell and natural killer cell neoplasm not peripheral T cell or extranodal NK/T cell or primary T cell cutaneous lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid mature T-cell and natural killer cell neoplasm other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-monoclonal-b-cell-lymphocytosis-histology"
        },
        "description": "Histologies used for monoclonal B-cell lymphocytosis (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid monoclonal B cell lymphocytosis histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mds-myeloproliferative-histology"
        },
        "description": "Histologies used for myelodysplastic and myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-mds-myeloproliferative-histology"
        },
        "description": "Histologies used for myelodysplastic and myeloproliferative neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mds-myeloproliferative-other-histology"
        },
        "description": "Histologies used for myelodysplastic and myeloproliferative neoplasm not chronic myelomonocytic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myelodysplastic and myeloproliferative neoplasm other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mds-histology"
        },
        "description": "Histologies used for myelodysplastic syndrome (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myelodysplastic syndrome histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-mds-histology"
        },
        "description": "Histologies used for myelodysplastic syndrome (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myelodysplastic syndrome histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-myeloid-other-histology"
        },
        "description": "Histologies used for other myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myeloid proliferation or neoplasm other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-myeloid-lymphoid-gene-histology"
        },
        "description": "Histologies used for myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myeloid/lymphoid neoplasm with eosinophilia and defining gene rearrangement histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-myeloma-histology"
        },
        "description": "Histologies used for myeloma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myeloma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-mpn-other-histology"
        },
        "description": "Histologies used for myeloproliferative neoplasm which are not primary myelofibrosis, essential thrombocythemia, polycythemia vera, chronic myeloid leukaemia, chronic eosinophilic leukaemia, juvenile myelomonocytic leukaemia, (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid myeloproliferative neoplasm other leukaemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-nhl-histology"
        },
        "description": "Histologies used for non Hodgkin lymphoma (WHO Classification of tumours, Haematolymphoid Tumours, 5th edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid non Hodgkin lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-peripheral-t-cell-lymphoma-histology"
        },
        "description": "Histologies used for peripheral T cell lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid peripheral T cell lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-plasma-cell-other-histology"
        },
        "description": "Histologies used for plasma cell neoplasms and other diseases with paraprotiens that are not amyloidosis or multiple myeloma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid plasma cell neoplasm and other diseases with paraproteins other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-plasma-cell-histology"
        },
        "description": "Histologies used for plasma cell neoplasms and other diseases with paraproteins (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid plasma cell neoplasms and other diseases with paraproteins histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-histology-plasmacytoid-dendritic-histology"
        },
        "description": "Histologies used for plasmacytoid dendritic cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid plasmacytoid dendritic cell neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-pv-histology"
        },
        "description": "Histologies used for polycythemia vera (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid polycythaemia vera histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-primary-cns-lymphoma-histology"
        },
        "description": "Histologies used for primary central nervous system lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid primary CNS lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-cutaneous-t-cell-lymphoma-histology"
        },
        "description": "Histologies used for primary cutaneous T cell lymphoproliferative disorder (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-cutaneous-t-cell-lymphoma-histology"
        },
        "description": "Histologies used for primary cutaneous T cell lymphoproliferative disorder (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid primary cutaneous T cell lymphoproliferative disorder histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-b-cell-reactive-lymphoma-histology"
        },
        "description": "Histologies used for reactive B-cell rich lymphoid proliferations that can mimic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid reactive B-cell rich lymphoid proliferations which mimic lymphoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-sll-histology"
        },
        "description": "Histologies used for small lymphocytic lymphoma (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition)",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid small lymphocytic lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-sys-mastocytosis-histology"
        },
        "description": "Histologies used for systemic mastocytosis (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid systemic mastocytosis histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-all-tcell-histology"
        },
        "description": "Histologies used for t lymphoblastic leukemia (WHO Classification of Tumours, Haematolymphoid Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid T lymphoblastic leukemia histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-t-nk-cell-other-histology"
        },
        "description": "Histologies used for T-cell and natural killer cell neoplasm (WHO Classification of Tumours, Haematolymphoid Tumours latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid T-cell and natural killer cell neoplasm other histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-haematology-histology"
        },
        "description": "Histologies used for haematolymphoid cancer types (WHO Classification of Tumours, Haematolymphoid Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO haematolymphoid tumour histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-heart-primary-histology"
        },
        "description": "Histologies used for heart primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 4. Tumours of the heart, 5. Mesenchymal tumours of the thorax, 7. Germ cell tumours of the mediastinum and 9. Ectopic tumours of thyroid and parathyroid origin) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO heart primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-b-cell-histology"
        },
        "description": "Histologies used for B cell lymphoid proliferations and lymphomas (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 4. B cell lymphoid proliferations and lymphomas) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO hematolymphoid B cell lymphoid proliferation or lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-histiocytic-histology"
        },
        "description": "Histologies used for histiocytic and dendritic cell neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 3. Histiocytic/Dendritic cell neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO hematolymphoid histiocytic dendritic cell neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-myeloid-histology"
        },
        "description": "Histologies used for myeloid proliferations and neoplasms (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 2. Myeloid proliferations and neoplasms excluding secondary myeloid neoplasm) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO hematolymphoid myeloid proliferation or neoplasm histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-stroma-histology"
        },
        "description": "Histologies used for stroma-derived neoplasms of lymphoid tissues (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 6. Stroma-derived neoplasms of lymphoid tissues) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO hematolymphoid stroma derived neoplasm of lymphoid tissue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-haematology-t-nk-cell-histology"
        },
        "description": "Histologies used for T cell and NK cell lymphoid proliferations and lymphomas (WHO Classification of Tumours, Haematolymphoid Tumours, latest edition - 5. T cell and NK cell lymphoid proliferations and lymphomas) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO hematolymphoid T cell and NK cell lymphoid proliferation or lymphoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-histology"
        },
        "description": "Histologies used for any cancer type (WHO Classification of Tumours, latest editions) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-kidney-primary-histology"
        },
        "description": "Histologies used for kidney primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO kidney primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-lacrimal-drainage-system-primary-histology"
        },
        "description": "Histologies used for lacrimal drainage system primaries, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 8. Tumours of the lacrimal drainage system or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO lacrimal drainage system primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-lacrimal-gland-primary-histology"
        },
        "description": "Histologies used for lacrimal gland primaries, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 7. Tumours of the lacrimal gland, 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO lacrimal gland primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-lacrimal-gland-site-histology"
        },
        "description": "Histologies used for lacrimal gland sites, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 7. Tumours of the lacrimal gland, 10. Haematolymphoid tumours, 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO lacrimal gland site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-liver-site-histology"
        },
        "description": "Histologies used for liver neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 8. Tumours of the liver and intrahepatic bile ducts, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Germ cell tumours only)) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO liver site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-lower-gastro-primary-histology"
        },
        "description": "Histologies used for lower gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix, 6. Tumours of the colon and rectum, 7. Tumours of the anal canal, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO lower gastrointestinal primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-lower-gastro-site-histology"
        },
        "description": "Histologies used for lower gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 5. Tumours of the appendix, 6. Tumours of the colon and rectum, 7. Tumours of the anal canal, 11. Haematolymphoid tumours of the digestive system 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO lower gastrointestinal site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-male-breast-primary-histology"
        },
        "description": "Histologies used for male breast primaries (excluding benign), from WHO Classification of Tumours, Breast Tumours (latest edition) - Sections 3. Fibroepithelial tumours and hamartomas of the breast, 4. Tumours of the nipple, 5. Mesenchymal tumours of the breast, 7. Tumours of the male breast or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO male breast primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-differentiation-excl-undifferentiated-grade"
        },
        "description": "A subset of the maximal differentiation grading reference set (excluding G4; undifferentiated grade), described by World Health Organization.",
        "exampleBoolean": false,
        "name": "NZ WHO malignant differentiation excluding undifferentiated grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-differentiation-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours differentiation grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO malignant differentiation grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-low-high-diff-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours low / high (differentiation) grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO malignant low high (differentiation) grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-mo-histology"
        },
        "description": "Histologies used for any medical oncology cancer site (WHO Classification of Tumours, latest editions) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO medical oncology histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-meninges-primary-histology"
        },
        "description": "Histologies used for meninges primaries, from WHO Classification of Tumours, Central Nervous System Tumours (latest edition) - 7. Meningioma, 8. Mesenchymal, non-meningothelial tumours involving the CNS, 9. Melanocytic tumours, 12. Tumours of the sellar region or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO meninges primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-neuroendo-non-endo-organ-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 8. Neuroendocrine neoplasms in non-endocrine organs or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine neoplasm non neuroendocrine organ histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-neuroendo-pancreas-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 7. Pancreatic neuroendocrine neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine pancreas histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-neuroendo-pancreas-histology"
        },
        "description": "Histologies used for endocrine and neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 7. Pancreatic neuroendocrine neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine pancreas histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-neuroendo-pancreas-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 7. Pancreatic neuroendocrine neoplasms 9. Mesenchymal and stromal tumours, and 11. Germ cell tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine pancreas primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-gep-net-primary-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 7. Pancreatic neuroendocrine neoplasms, neuroendocrine tumours 8. Neuroendocrine neoplasms in non-endocrine organs neuroendocrine tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine tumour gastroenteropancreatic (GEP-NET) primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-neuroendocrine-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours neuroendocrine tumour grading system.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine tumour grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-net-non-endo-organ-primary-histology"
        },
        "description": "Histologies used for neuroendocrine tumours (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 8. Neuroendocrine neoplasms in non-endocrine organs neuroendocrine tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-net-non-endo-organ-histology"
        },
        "description": "Histologies used for neuroendocrine tumours (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 8. Neuroendocrine neoplasms in non-endocrine organs neuroendocrine tumours excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine tumour non neuroendocrine organ primary histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-neuroendo-pancreas-net-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 7. Pancreatic neuroendocrine neoplasms, neuroendocrine tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO neuroendocrine tumour pancreas primary histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-oesophagus-primary-histology"
        },
        "description": "Histologies used for oesophagus primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO oesophagus primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-orbit-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, latest edition - 9. Tumours of the orbit) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO orbit histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-orbit-histology"
        },
        "description": "Histologies used for eye and orbit cancer types (WHO Classification of Tumours, Eye and Orbit Tumours, 5th edition - 9. Tumours of the orbit) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO orbit histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-orbit-primary-histology"
        },
        "description": "Histologies used for orbit primaries, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 9. Tumours of the orbit, 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO orbit primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-ovary-primary-histology"
        },
        "description": "Histologies used for ovary primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 2. Tumours of the ovary, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO ovary primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-ovary-site-histology"
        },
        "description": "Histologies used for ovary sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 2. Tumours of the ovary, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO ovary site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-pancreas-primary-histology"
        },
        "description": "Histologies used for pancreatic primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 10. Tumours of the pancreas,12. Mesenchymal tumours of the digestive system) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO pancreas primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-pancreas-site-histology"
        },
        "description": "Histologies used for pancreatic neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 10. Tumours of the pancreas, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO pancreas site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-penis-primary-histology"
        },
        "description": "Histologies used for penis primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO penis primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-penis-site-histology"
        },
        "description": "Histologies used for penis sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO penis site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-pericardium-primary-histology"
        },
        "description": "Histologies used for pericardium primaries (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium (excluding haematolymphoid tumours), 5. Mesenchymal tumours of the thorax, 7. Germ cell tumours of the mediastinum and 9. Ectopic tumours of thyroid and parathyroid origin) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO pericardium primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-pericardium-site-histology"
        },
        "description": "Histologies used for pericardium neoplasms (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium, 5. Mesenchymal tumours of the thorax, 7. Germ cell tumours of the mediastinum, 8. Haematolymphoid tumours of the mediastinum, and 9. Ectopic tumours of thyroid and parathyroid origin) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO pericardium site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-peritoneum-site-histology"
        },
        "description": "Histologies used for peritoneum sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 4. Tumours of the peritoneum, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions, Endometriosis or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO peritoneum site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-endo-neuroendo-primary-pituitary-net-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, latest edition) 2. Pituitary tumours section Anterior pituitary neuroendocrine tumours (PitNETs).",
        "exampleBoolean": false,
        "name": "NZ WHO pituitary neuroendocrine tumour primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-endo-neuroendo-pituitary-net-histology"
        },
        "description": "Histologies used for endocrine and Neuroendocrine cancer types (WHO Classification of Tumours, Endocrine and Neuroendocrine Tumours, 5th edition) 2. Pituitary tumours section Anterior pituitary neuroendocrine tumours (PitNETs).",
        "exampleBoolean": false,
        "name": "NZ WHO pituitary neuroendocrine tumour primary histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-pleura-site-histology"
        },
        "description": "Histologies used for pleural neoplasms (from WHO Classification of Tumours, Thoracic Tumours, latest edition, including sections 3. Tumours of the pleura and pericardium and 5. Mesenchymal tumours of the thorax) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO pleural site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-prostate-primary-histology"
        },
        "description": "Histologies used for prostate primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO prostate primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-prostate-site-histology"
        },
        "description": "Histologies used for prostate sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO prostate site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-sclera-primary-histology"
        },
        "description": "Histologies used for sclera primaries, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 11. Soft tissue and bone tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO sclera primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-small-intestine-primary-histology"
        },
        "description": "Histologies used for small intestine primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 4. Tumours of the small intestine and ampulla,, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO small intestine primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-small-intestine-site-histology"
        },
        "description": "Histologies used for small intestine neoplasms(from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 4. Tumours of the small intestine and ampulla, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO small intestine site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-soft-tissue-bone-undiff-sarcoma-histology"
        },
        "description": "Histologies used for soft tissue and bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 3. Undifferentiated small round cell sarcoma of bone and soft tissue) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-soft-tissue-bone-undiff-sarcoma-histology"
        },
        "description": "Histologies used for soft tissue and bone cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, 5th edition - 3. Undifferentiated small round cell sarcoma of bone and soft tissue) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO soft tissue and bone undifferentiated small round cell sarcoma histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-soft-tissue-histology"
        },
        "description": "Histologies used for soft tissue cancer types (WHO Classification of Tumours, Soft Tissue & Bone Tumours, latest edition - 2. Soft tissue tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO soft tissue histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-soft-tissue-primary-histology"
        },
        "description": "Histologies used for soft tissue primaries, from WHO Classification of Tumours, Soft Tissue & Bone Tumours (latest edition) - 2. Soft tissue tumours, 3. Undifferentiated small round cell sarcomas of bone and soft tissue or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO soft tissue primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-soft-tissue-site-histology"
        },
        "description": "Histologies used for soft tissue sites, from WHO Classification of Tumours, Soft Tissue & Bone Tumours (latest edition) - 2. Soft tissue tumours, 3. Undifferentiated small round cell sarcomas of bone and soft tissue or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO soft tissue site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-spinal-cord-site-histology"
        },
        "description": "Histologies used for spinal cord sites, from WHO Classification of Tumours, Central Nervous System Tumours (latest edition) - 2. Gliomas, glioneuronal tumours, and neuronal tumours, 4. Embyronal tumours, 8. Mesenchymal, non-meningothelial tumours involving the CNS, 9. Melanocytic tumours, 10. Haematolymphoid tumours involving the CNS or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO spinal cord site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-stomach-primary-histology"
        },
        "description": "Histologies used for stomach primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 3. Tumours of the stomach,12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO stomach primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-testicular-adnexa-primary-histology"
        },
        "description": "Histologies used for testicular adnexa primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO testicular adnexa primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-testicular-adnexa-site-histology"
        },
        "description": "Histologies used for testicular adnexa sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 7. Tumours of the testicular adnexa, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO testicular adnexa site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-testis-primary-histology"
        },
        "description": "Histologies used for testies primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 6. Tumours of the testis, 9. Neuroendocrine neoplasms, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO testis primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-testis-site-histology"
        },
        "description": "Histologies used for testies sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 6. Tumours of the testis, 9. Neuroendocrine neoplasms, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO testis site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-benign-histology"
        },
        "description": "Histologies used for thoracic benign cancer types (WHO Classification of Tumours, Thoracic Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic benign histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-benign-histology"
        },
        "description": "Histologies used for thoracic benign cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic benign histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-ectopic-thyroid-parathyroid-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 9. Ectopic tumours of thyroid and parathyroid origin or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-ectopic-thyroid-parathyroid-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 9. Ectopic tumours of thyroid and parathyroid origin or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic ectopic tumour of thyroid and parathyroid origin histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-haematolymphoid-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours) 8. Haematolymphoid tumours of the mediastinum and heamtolymphoid subsections in 2. Tumours of the lung, 3. Tumours of the pleura and pericardium and 4. Tumours of the heart or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic haematolymphoid histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-heart-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 4. Tumours of the heart or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic heart histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-malignant-histology"
        },
        "description": "Histologies used for thoracic uncertain behaviour cancer types (WHO Classification of Tumours, Thoracic Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic malignant histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-germ-cell-mediastinum-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 7. Germ cell tumours of the mediastinum or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic mediastinum germ cell histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-haematolymphoid-mediastinum-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 8. Haematolymphoid tumours of the mediastinum or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic mediastinum haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-mesenchymal-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 5. Mesenchymal tumours of the thorax or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic mesenchymal thorax histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-neuroendocrine-grade"
        },
        "description": "The grade of a cancer, assessed using the WHO Classification of Tumours atypical or typical neuroendocrine tumour grading system for thoracic tumours.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic neuroendocrine tumour grade"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-non-small-cell-lung-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 2. Tumours of the lung. Non small cell histology or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic non small cell lung histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-non-small-cell-lung-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 2. Tumours of the lung. Non small cell histology or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic non small cell lung histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-pleura-pericardium-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 3. Tumours of the pleura and pericardium or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic pleura and pericardium histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-pleura-pericardium-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 3. Tumours of the pleura and pericardium or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic pleura and pericardium histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-precursor-histology"
        },
        "description": "Histologies used for thoracic precursor cancer types (WHO Classification of Tumours, Thoracic Tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic precursor histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-precursor-histology"
        },
        "description": "Histologies used for thoracic precursor cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic precursor histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-primary-histology"
        },
        "description": "Histologies used for thoracic cancer types excluding heamatological histologies and benign neoplasm (WHO Classification of Tumours, Thoracic Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-thoracic-small-cell-lung-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, latest edition) 2. Tumours of the lung. Small cell histology or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic small cell lung histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-thoracic-small-cell-lung-histology"
        },
        "description": "Histologies used for thoracic cancer types (WHO Classification of Tumours, Thoracic Tumours, 5th edition) 2. Tumours of the lung. Small cell histology or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO thoracic small cell lung histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-upper-gastro-primary-histology"
        },
        "description": "Histologies used for upper gastrointestinal primaries (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 3. Tumours of the stomach, 4. Tumours of the small intestine and ampulla, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) excluding benign neoplasms or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO upper gastrointestinal primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-upper-gastro-site-histology"
        },
        "description": "Histologies used for upper gastrointestinal neoplasms (from WHO Classification of Tumours, Digestive Tumours, latest edition, including sections 2. Tumours of the oesophagus, 3. Tumours of the stomach, 4. Tumours of the small intestine and ampulla, 11. Haematolymphoid tumours of the digestive system, 12. Mesenchymal tumours of the digestive system, 13. Other tumours of the digestive system (Melanoma only)) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO upper gastrointestinal site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urethra-primary-histology"
        },
        "description": "Histologies used for urethra primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urethra primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urethra-site-histology"
        },
        "description": "Histologies used for urethra sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urethra site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-urinary-male-genital-haematolymphoid-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 11. Haematolymphoid tumours) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital haematolymphoid histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-urinary-male-genital-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-kidney-germ-cell-histology"
        },
        "description": "Histologies used for germ cell tumours of kidney (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital kidney germ cell histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-kidney-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 2. Tumours of the kidney) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital kidney histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-urinary-male-genital-kidney-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 2. Tumours of the kidney) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital kidney histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-neuroendocrine-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 9. Neuroendocrine neoplasms) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital neuroendocrine histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-primary-histology"
        },
        "description": "Histologies used for urinary and male genital primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 3. Tumours of the urinary tract, 4. Tumours of the prostate, 5. Tumours of the seminal vesicle, 6. Tumours of the testis, 7. Tumours of the testicular adnexa, 8. Tumours of the penis and scrotum, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-prostate-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 4. Tumours of the prostate) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital prostate histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-urinary-male-genital-prostate-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition - 4. Tumours of the prostate) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital prostate histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-testicular-adnexa-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 7. Tumours of the tesicular adnexa) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital testicular adnexa histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-testis-germ-cell-histology"
        },
        "description": "Histologies used for germ cell tumours of testis (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital testis germ cell histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who5-urinary-male-genital-testis-germ-cell-histology"
        },
        "description": "Histologies used for germ cell tumours of testis (WHO Classification of Tumours, Urinary & Male Genital Tumours, 5th edition) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital testis germ cell histology (5th edition)"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-male-genital-testis-histology"
        },
        "description": "Histologies used for urinary and male genital cancer types (WHO Classification of Tumours, Urinary & Male Genital Tumours, latest edition - 6. Tumours of the testis) or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary and male genital testis histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-bladder-primary-histology"
        },
        "description": "Histologies used for urinary bladder primaries, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary bladder primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-urinary-system-site-histology"
        },
        "description": "Histologies used for urinary system sites, from WHO Classification of Tumours, Urinary & Male Genital Tumours (latest edition) - Sections 2. Tumours of the kidney, 3. Tumours of the urinary tract, 9. Neuroendocrine neoplasms, 10. Mesenchymal tumours, 11. Haematolymphoid tumours, 12. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO urinary system site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-uterine-corpus-primary-histology"
        },
        "description": "Histologies used for uterine corpus primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 7. Tumours of the uterine corpus, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO uterine corpus primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-uterine-corpus-site-histology"
        },
        "description": "Histologies used for uterine corpus sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 7. Tumours of the uterine corpus, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO uterine corpus site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-uterine-ligament-site-histology"
        },
        "description": "Histologies used for uterine ligament sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 6. Tumours of the broad ligament and other uterine ligaments, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO uterine ligament site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-uterine-primary-histology"
        },
        "description": "Histologies used for uterine primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 6.Tumour of the broad ligament and other uterine ligaments, 7. Tumours of the uterine corpus, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO uterine primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-uveal-tract-site-histology"
        },
        "description": "Histologies used for uveal tract sites, from WHO Classification of Tumours, Eye and Orbit Tumours (latest edition) - 4. Tumours of the uveal tract, 10. Haematolymphoid tumours or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO uveal tract site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-vagina-site-histology"
        },
        "description": "Histologies used for vagina sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 10. Tumours of the vagina, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO vagina site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-vulva-primary-histology"
        },
        "description": "Histologies used for vulva primaries, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 11. Tumours of the vulva, 12. Neuroendocrine neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO vulva primary histology"
      },
      {
        "reference": {
          "reference": "ValueSet/canshare-who-vulva-site-histology"
        },
        "description": "Histologies used for vulva sites, from WHO Classification of Tumours, Female Genital Tumours (latest edition) - Sections 11. Tumours of the vulva, 12. Neuroendocrine neoplasia, 13. Haematolymphoid proliferations and neoplasia, 14. Mesenchymal tumours of the lower genital tract, 15. Melanocytic lesions or an 'Other' value.",
        "exampleBoolean": false,
        "name": "NZ WHO vulva site histology"
      },
      {
        "reference": {
          "reference": "ValueSet/nz-datum-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/nz-datum-code",
        "exampleBoolean": false,
        "name": "nz-datum-code"
      },
      {
        "reference": {
          "reference": "ValueSet/nz-ethnic-group-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/nz-ethnic-group-codes",
        "exampleBoolean": false,
        "name": "nz-ethnic-group-code"
      },
      {
        "reference": {
          "reference": "OperationOutcome/NZ-residency-source-code"
        },
        "exampleBoolean": false,
        "name": "NZ-residency-source-code"
      },
      {
        "reference": {
          "reference": "ValueSet/nzmt-type-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/nzmt-type-code",
        "exampleBoolean": false,
        "name": "nzmt-type-code"
      },
      {
        "reference": {
          "reference": "ValueSet/nzpocs"
        },
        "description": "A LOINC FHIR ValueSet of NZPOCS Observation Code Set",
        "exampleBoolean": false,
        "name": "NZPOCS"
      },
      {
        "reference": {
          "reference": "CodeSystem/f42a2f22-aa0a-4f67-b0d6-74e78376527d"
        },
        "exampleBoolean": false,
        "name": "NZVX immunisation codes"
      },
      {
        "reference": {
          "reference": "OperationOutcome/observation-codes"
        },
        "exampleBoolean": false,
        "name": "observation-codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/omaha-system"
        },
        "description": "Omaha System CodeSystem including various domains.",
        "exampleBoolean": false,
        "name": "Omaha System CodeSystem"
      },
      {
        "reference": {
          "reference": "CodeSystem/OralEnrolmentTerminationReason"
        },
        "exampleBoolean": false,
        "name": "Oral health enrolment termination reason code"
      },
      {
        "reference": {
          "reference": "ValueSet/oral-enrolment-termination-reason"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/oral-enrolment-termination-reason-code",
        "exampleBoolean": false,
        "name": "oral-enrolment-termination-reason"
      },
      {
        "reference": {
          "reference": "CodeSystem/pho-status"
        },
        "description": "Primary Healthcare Organization",
        "exampleBoolean": false,
        "name": "PHO"
      },
      {
        "reference": {
          "reference": "ValueSet/practitioner-additional-authorisation-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/practitioner-additional-authorisation-code",
        "exampleBoolean": false,
        "name": "practitioner-additional-authorisation-code"
      },
      {
        "reference": {
          "reference": "ValueSet/practitioner-scope-of-practice-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/practitioner-scope-of-practice-code",
        "exampleBoolean": false,
        "name": "practitioner-scope-of-practice-code"
      },
      {
        "reference": {
          "reference": "CodeSystem/hpi-practitionerRole-status-reason"
        },
        "description": "The reason for the current status of PractitionerRole",
        "exampleBoolean": false,
        "name": "PractitionerRole status reason"
      },
      {
        "reference": {
          "reference": "ValueSet/practitioner-role-code"
        },
        "description": "The role a practitioner holds.",
        "exampleBoolean": false,
        "name": "PractitionerRoleCode"
      },
      {
        "reference": {
          "reference": "ValueSet/pregnancies-summary-uv-ips"
        },
        "description": "IPS Pregnancies Summary",
        "exampleBoolean": false,
        "name": "Pregnancies Summary - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/edd-method-uv-ips"
        },
        "description": "IPS Expected Delivery Date Method",
        "exampleBoolean": false,
        "name": "Pregnancy Expected Delivery Date Method - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/pregnancy-status-uv-ips"
        },
        "description": "IPS Pregnancy Status",
        "exampleBoolean": false,
        "name": "Pregnancy Status - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/condition-severity-uv-ips"
        },
        "description": "Problem Severity. The [condition-severity](https://www.hl7.org/fhir/R4/valueset-condition-severity.html) value set from the base Condition resource is now the preferred binding for IPS.  This value set of LOINC answer codes is retained as an additional binding for backward compatibility with the prior IPS release.",
        "exampleBoolean": false,
        "name": "Problem Severity - IPS"
      },
      {
        "reference": {
          "reference": "OperationOutcome/problems-snomed-absent-unknown-uv-ips"
        },
        "exampleBoolean": false,
        "name": "problems-snomed-absent-unknown-uv-ips"
      },
      {
        "reference": {
          "reference": "OperationOutcome/procedures-snomed-absent-unknown-uv-ips"
        },
        "exampleBoolean": false,
        "name": "procedures-snomed-absent-unknown-uv-ips"
      },
      {
        "reference": {
          "reference": "CodeSystem/practitioner-registration-status-code"
        },
        "description": "The code list represents the current practicing status of the Provider Person as per their registration with an RA.",
        "exampleBoolean": false,
        "name": "Registration Status of Practitioners"
      },
      {
        "reference": {
          "reference": "OperationOutcome/request-status"
        },
        "exampleBoolean": false,
        "name": "request-status"
      },
      {
        "reference": {
          "reference": "ValueSet/results-coded-values-laboratory-uv-ips"
        },
        "description": "This value set is defined as the union of: (a) Blood group [Type]; (b) Presence/Absence Indicators (2.16.840.1.113883.11.22.52) (c) Microorganisms (2.16.840.1.113883.11.22.49)",
        "exampleBoolean": false,
        "name": "Results Coded Values Laboratory - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/result-coded-value-pathology-uv-ips"
        },
        "description": "This value set includes codes from SNOMED Clinical Terms (SNOMED CT®) that are included in:  all descendants of 106253005 \\|Histologic grading differentiation AND/OR behavior (qualifier value)\\|, all descendants of 373369003 \\|Finding of histologic grading differentiation AND/OR behavior (finding)\\|, all descendants of 399981008 \\|Neoplasm and/or hamartoma (disorder)\\|.",
        "exampleBoolean": false,
        "name": "Results Coded Values Pathology - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/results-pathology-observations-uv-ips"
        },
        "description": "Value Set Definition:\n\n LOINC {STATUS in {ACTIVE}, CLASSTYPE in {1}, CLASS in {CYTO, HL7.CYTOGEN, HL7.GENETICS, MOLPATH, MOLPATH.\\*, PATH, PATH.\\*}}",
        "exampleBoolean": false,
        "name": "Results Pathology Observation - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/results-presence-absence-uv-ips"
        },
        "description": "Presence/Absence value set",
        "exampleBoolean": false,
        "name": "Results Presence/Absence - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/results-radiology-observations-uv-ips"
        },
        "description": "Value Set Definition: \n LOINC {CLASS in {RAD}}",
        "exampleBoolean": false,
        "name": "Results Radiology Observation - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/results-specimen-collection-method-uv-ips"
        },
        "description": "IPS Specimen Collection Method",
        "exampleBoolean": false,
        "name": "Results Specimen Collection Method - IPS"
      },
      {
        "reference": {
          "reference": "ValueSet/results-specimen-type-uv-ips"
        },
        "description": "IPS Specimen Type value set. This value set includes a set of codes from SNOMED CT that may be used to represent specimen types.",
        "exampleBoolean": false,
        "name": "Results Specimen Type - IPS"
      },
      {
        "reference": {
          "reference": "OperationOutcome/results-radiology-numobs-snomed-dicom-uv-ips"
        },
        "exampleBoolean": false,
        "name": "results-radiology-numobs-snomed-dicom-uv-ips"
      },
      {
        "reference": {
          "reference": "OperationOutcome/results-radiology-txtobs-snomed-dicom-loinc-uv-ips"
        },
        "exampleBoolean": false,
        "name": "results-radiology-txtobs-snomed-dicom-loinc-uv-ips"
      },
      {
        "reference": {
          "reference": "ValueSet/NZRhFCarePlanCategory"
        },
        "description": "Value set to support FHIR resource for identifying the rheumatic fever care plan being provided.",
        "exampleBoolean": false,
        "name": "Rheumatic fever care plan category"
      },
      {
        "reference": {
          "reference": "ValueSet/NZRhFCareTeamParticipantRole"
        },
        "exampleBoolean": false,
        "name": "Rheumatic fever care team participant role"
      },
      {
        "reference": {
          "reference": "CodeSystem/NZRhFDiagnosticCertaintyCS"
        },
        "description": "This list to support rheumatic fever collection.",
        "exampleBoolean": false,
        "name": "Rheumatic fever diagnostic certainty"
      },
      {
        "reference": {
          "reference": "CodeSystem/scopeOfPractice"
        },
        "description": "A classification of the type or range of health services that a practitioner is authorised to provide, as determined by the Responsible Authority or other statutory authority (e.g. PHARMAC), that is, what the practitioner can or cannot do. It includes Scope of Practice as defined by the Health Practitioners Competence Assurance Act 2003, any special authorisations granted, and any conditions or limitations imposed by the Responsible Authority.",
        "exampleBoolean": false,
        "name": "Scope of practice"
      },
      {
        "reference": {
          "reference": "OperationOutcome/service-type"
        },
        "exampleBoolean": false,
        "name": "service-type"
      },
      {
        "reference": {
          "reference": "CodeSystem/ec568eb5-083c-4893-a393-eecbde4028bb"
        },
        "description": "Reason why initial skin to skin contact was ended",
        "exampleBoolean": false,
        "name": "Skin to skin end reason"
      },
      {
        "reference": {
          "reference": "ValueSet/skin-to-skin-contact-end-reason-code"
        },
        "description": "All codes for https://standards.digital.health.nz/ns/skin-to-skin-contact-end-reason-code",
        "exampleBoolean": false,
        "name": "skin-to-skin-contact-end-reason-code"
      },
      {
        "reference": {
          "reference": "ValueSet/26bb5eb0-11c0-4f53-a9dc-6dbf2c18dfd0"
        },
        "exampleBoolean": false,
        "name": "Smoking status"
      },
      {
        "reference": {
          "reference": "CodeSystem/900000000000207008-20230131"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "SNOMED CT core"
      },
      {
        "reference": {
          "reference": "CodeSystem/900000000000207008-20230731"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "SNOMED CT core"
      },
      {
        "reference": {
          "reference": "CodeSystem/900000000000207008-20240101"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "SNOMED CT core"
      },
      {
        "reference": {
          "reference": "CodeSystem/900000000000207008-20240201"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "SNOMED CT core"
      },
      {
        "reference": {
          "reference": "CodeSystem/900000000000207008-20240801"
        },
        "description": "SNOMED CT is the most comprehensive and precise clinical health terminology product in the world, owned and distributed around the world by The International Health Terminology Standards Development Organisation (IHTSDO).",
        "exampleBoolean": false,
        "name": "SNOMED CT core"
      },
      {
        "reference": {
          "reference": "ValueSet/reason-medication-status-codes"
        },
        "description": "This value set includes some taken and not taken reason codes from SNOMED CT - provided as an exemplar",
        "exampleBoolean": false,
        "name": "SNOMED CT Drug Therapy Status codes "
      },
      {
        "reference": {
          "reference": "ValueSet/gender-classification"
        },
        "exampleBoolean": false,
        "name": "Standard classification of gender"
      },
      {
        "reference": {
          "reference": "CodeSystem/93753db5-d066-4452-8ef8-76c20c781a9b"
        },
        "description": "SNOMED CT identifiers assigned to Rheumatic Fever concepts that will not be available until April 2024 edition. Codesystem need to be retired once they have been uploaded in SNOMED NZ Edition",
        "exampleBoolean": false,
        "name": "Temporary rheumatic fever codes"
      },
      {
        "reference": {
          "reference": "CodeSystem/alias-type"
        },
        "description": "Used in Organization and Location to indicate what is the type of Alias",
        "exampleBoolean": false,
        "name": "Type of Alias"
      },
      {
        "reference": {
          "reference": "ValueSet/ucum-units"
        },
        "description": "Unified Code for Units of Measure (UCUM). This value set includes all UCUM codes",
        "exampleBoolean": false,
        "name": "UCUM Codes"
      },
      {
        "reference": {
          "reference": "ValueSet/ukpul-vs"
        },
        "description": "FHIR ValueSet for UKPUL",
        "exampleBoolean": false,
        "name": "UKPUL"
      },
      {
        "reference": {
          "reference": "CodeSystem/v3-ucum"
        },
        "description": "The Unified Code for Units of Measure (UCUM) is a code system intended to include all units of measures being contemporarily used in international science, engineering, and business. The purpose is to facilitate unambiguous electronic communication of quantities together with their units. The focus is on electronic communication, as opposed to communication between humans. A typical application of The Unified Code for Units of Measure are electronic data interchange (EDI) protocols, but there is nothing that prevents it from being used in other types of machine communication.",
        "exampleBoolean": false,
        "name": "Unified Code for Units of Measure (UCUM)"
      },
      {
        "reference": {
          "reference": "CodeSystem/1587f987-b621-4494-b76d-cbad95f862c7"
        },
        "description": "HISO 10050 Uterotonic drugs administered status, as part of the third stage of labour.",
        "exampleBoolean": false,
        "name": "Uterotonic drugs administered status code"
      },
      {
        "reference": {
          "reference": "CodeSystem/v3-ActReason"
        },
        "description": " A set of codes specifying the motivation, cause, or rationale of an Act, when such rationale is not reasonably represented as an ActRelationship of type \"has reason\" linking to another Act.  Examples:\r\nExample reasons that might qualify for being coded in this field might be: \"routine requirement\", \"infectious disease reporting requirement\", \"on patient request\", \"required by law\".",
        "exampleBoolean": false,
        "name": "v3 Code System ActReason"
      },
      {
        "reference": {
          "reference": "CodeSystem/CVX"
        },
        "description": "The CDC's National Center of Immunization and Respiratory Diseases developed and maintains the CVX (vaccine administered) code set. It includes both active and inactive vaccines available in the US.",
        "exampleBoolean": false,
        "name": "Vaccine Administered Code Set (CVX)"
      },
      {
        "reference": {
          "reference": "ValueSet/vaccine-code"
        },
        "description": "All codes for http://hl7.org/fhir/sid/cvx",
        "exampleBoolean": false,
        "name": "vaccine-code"
      },
      {
        "reference": {
          "reference": "OperationOutcome/vaccines-uv-ips"
        },
        "exampleBoolean": false,
        "name": "vaccines-uv-ips"
      },
      {
        "reference": {
          "reference": "ValueSet/observation-vitalsignresult"
        },
        "description": "This value set indicates the allowed vital sign result types.   The LOINC code for Vitals Signs panel (85353-1) is a grouping structure for a set of vital signs and includes related links (with type=has-member) to the Observations in this set (e.g. respiratory rate, heart rate, BP).  The Blood pressure panel (85354-9) is used to group the component observations Systolic blood pressure (8480-6) and Diastolic blood pressure (8462-4).",
        "exampleBoolean": false,
        "name": "Vital Signs"
      }
    ],
    "page": {
      "nameUrl": "toc.html",
      "title": "Table of Contents",
      "generation": "html",
      "page": [
        {
          "nameUrl": "index.html",
          "title": "Home",
          "generation": "markdown"
        }
      ]
    },
    "parameter": [
      {
        "code": "copyrightyear",
        "value": "2024+"
      },
      {
        "code": "releaselabel",
        "value": "ci-build"
      },
      {
        "code": "no-narrative",
        "value": "CodeSystem/*"
      },
      {
        "code": "no-narrative",
        "value": "ValueSet/*"
      },
      {
        "code": "no-narrative",
        "value": "ConceptMap/*"
      },
      {
        "code": "no-validate",
        "value": "CodeSystem/*"
      },
      {
        "code": "no-validate",
        "value": "ValueSet/*"
      },
      {
        "code": "no-validate",
        "value": "ConceptMap/*"
      },
      {
        "code": "no-check-usage",
        "value": "CodeSystem/*"
      },
      {
        "code": "no-check-usage",
        "value": "ValueSet/*"
      },
      {
        "code": "no-check-usage",
        "value": "ConceptMap/*"
      }
    ]
  }
}
